<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30544544</article-id>
<article-id pub-id-type="pmc">6321611</article-id>
<article-id pub-id-type="doi">10.3390/ijms19123929</article-id>
<article-id pub-id-type="publisher-id">ijms-19-03929</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Power of Fish Models to Elucidate Skin Cancer Pathogenesis and Impact the Discovery of New Therapeutic Opportunities</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sarasamma</surname>
<given-names>Sreeja</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-19-03929">1</xref>
<xref ref-type="aff" rid="af2-ijms-19-03929">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lai</surname>
<given-names>Yu-Heng</given-names>
</name>
<xref ref-type="aff" rid="af3-ijms-19-03929">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liang</surname>
<given-names>Sung-Tzu</given-names>
</name>
<xref ref-type="aff" rid="af2-ijms-19-03929">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Kechun</given-names>
</name>
<xref ref-type="aff" rid="af4-ijms-19-03929">4</xref>
<xref ref-type="corresp" rid="c1-ijms-19-03929">*</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6398-8672</contrib-id>
<name>
<surname>Hsiao</surname>
<given-names>Chung-Der</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-19-03929">1</xref>
<xref ref-type="aff" rid="af2-ijms-19-03929">2</xref>
<xref ref-type="aff" rid="af5-ijms-19-03929">5</xref>
<xref ref-type="aff" rid="af6-ijms-19-03929">6</xref>
<xref ref-type="corresp" rid="c1-ijms-19-03929">*</xref>
</contrib>
</contrib-group>
<aff id="af1-ijms-19-03929"><label>1</label>Department of Chemistry, Chung Yuan Christian University, Chung-Li 32023, Taiwan; <email>sreejakarthik@hotmail.com</email></aff>
<aff id="af2-ijms-19-03929"><label>2</label>Department of Bioscience Technology, Chung Yuan Christian University, Chung-Li 32023, Taiwan; <email>stliang3@gmail.com</email></aff>
<aff id="af3-ijms-19-03929"><label>3</label>Department of Chemistry, Chinese Culture University, Taipei 11114, Taiwan; <email>lyh21@ulive.pccu.edu.tw</email></aff>
<aff id="af4-ijms-19-03929"><label>4</label>Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China</aff>
<aff id="af5-ijms-19-03929"><label>5</label>Taiwan Center for Biomedical Technology, Chung Yuan Christian University, Chung-Li 32023, Taiwan</aff>
<aff id="af6-ijms-19-03929"><label>6</label>Center for Nanotechnology, Chung Yuan Christian University, Chung-Li 32023, Taiwan</aff>
<author-notes>
<corresp id="c1-ijms-19-03929"><label>*</label>Correspondence: <email>hliukch@sdas.org</email> (K.L.), <email>cdhsiao@cycu.edu.tw</email> (C.-D.H.); Tel.: +86-531-8260-5352 (K.L.), +886-3-265-3545 (C.-D.H.)</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>12</month>
<year>2018</year>
</pub-date>
<volume>19</volume>
<issue>12</issue>
<elocation-id>3929</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>12</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Â© 2018 by the authors.</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Animal models play important roles in investigating the pathobiology of cancer, identifying relevant pathways, and developing novel therapeutic tools. Despite rapid progress in the understanding of disease mechanisms and technological advancement in drug discovery, negative trial outcomes are the most frequent incidences during a Phase III trial. Skin cancer is a potential life-threatening disease in humans and might be medically futile when tumors metastasize. This explains the low success rate of melanoma therapy amongst other malignancies. In the past decades, a number of skin cancer models in fish that showed a parallel development to the disease in humans have provided important insights into the fundamental biology of skin cancer and future treatment methods. With the diversity and breadth of advanced molecular genetic tools available in fish biology, fish skin cancer models will continue to be refined and expanded to keep pace with the rapid development of skin cancer research. This review begins with a brief introduction of molecular characteristics of skin cancers, followed by an overview of teleost models that have been used in the last decades in melanoma research. Next, we will detail the importance of the zebrafish (<italic>Danio rerio</italic>) animal model and other emerging fish models including platyfish (<italic>Xiphophorus</italic> sp.), and medaka (<italic>Oryzias latipes</italic>) in future cutaneous malignancy studies. The last part of this review provides the recent development and genome editing applications of skin cancer models in zebrafish and the progress in small molecule screening.</p>
</abstract>
<kwd-group>
<kwd>skin cancer models</kwd>
<kwd>zebrafish</kwd>
<kwd>medaka</kwd>
<kwd>molecule screening</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-19-03929">
<title>1. Introduction</title>
<p>Skin cancer, which includes squamous cell carcinoma (SCC) and melanoma, represents the most common type of cutaneous malignancy around the world and incidence rates are continuing to increase [<xref ref-type="bibr" rid="B1-ijms-19-03929">1</xref>]. Melanoma is a major worldwide health problem due to its high prevalence and mortality rate. In 2018, the American Cancer Society estimates that approximately 91,270 people in the USA will be diagnosed with melanoma, and 9320 (about 5990 men and 3330 women) people are expected to die of melanoma skin cancer [<xref ref-type="bibr" rid="B2-ijms-19-03929">2</xref>]. Recent studies indicated that the incidence of melanoma has increased steadily in the last three decades (available online: <uri xlink:href="https://www.cancer.org/cancer/melanoma-skin-cancer/about/key-statistics.html">https://www.cancer.org/cancer/melanoma-skin-cancer/about/key-statistics.html</uri>). In a canonical model, melanoma with mutations induced by ultraviolet (UV) light may eventually lead to proliferation of melanocyte [<xref ref-type="bibr" rid="B3-ijms-19-03929">3</xref>]. After proliferation, the first response of melanocytes are to develop into oncogene-induced senescence (OIS), which further form benign nevus [<xref ref-type="bibr" rid="B4-ijms-19-03929">4</xref>]. Generally, UV light induces DNA damage in keratinocytes and melanocytes. Extreme UV exposure (sunburn) leads to massive death of keratinocytes, but melanocytes are able to survive due to efficient DNA damage repair response [<xref ref-type="bibr" rid="B5-ijms-19-03929">5</xref>]. Recently, exome sequencing in melanoma with high heterogeneity has identified a large catalogue of recurrent somatic variants, which were found to be mostly within the <italic>B-Raf proto-oncogene</italic>, <italic>serine/threonine kinase</italic> (<italic>BRAF</italic>) and <italic>Neuroblastoma RAS viral oncogene homolog</italic> (<italic>NRAS</italic>) genes [<xref ref-type="bibr" rid="B6-ijms-19-03929">6</xref>]. However, nearly 100% of the recurrence is due to rapidly emerging multi-drug resistance (MDR) [<xref ref-type="bibr" rid="B7-ijms-19-03929">7</xref>]. Novel genes have not yet been discovered in human melanoma expression studies and there is a lack of known and new candidate drug targets for further validation in malignant melanoma animal model [<xref ref-type="bibr" rid="B8-ijms-19-03929">8</xref>]. Therefore, a deep understanding of carcinogenesis in animal models is urgently needed to improve drug resistance in cancer therapy. So far, the existing melanoma animal models have been zebrafish, medaka, platyfish, the mouse, Syrian hamster, opossum and Mongolian gerbil [<xref ref-type="bibr" rid="B9-ijms-19-03929">9</xref>,<xref ref-type="bibr" rid="B10-ijms-19-03929">10</xref>]. Each of them has its own advantage and disadvantage in drug screening and molecular depiction of melanoma, and it will be discussed as follows.</p>
<p>Recently, there has been an increasing number of application of fish used as human disease models, especially in melanoma research. It is well-known that humans and fish share very few differences at the molecular level [<xref ref-type="bibr" rid="B11-ijms-19-03929">11</xref>]. For instance, human <italic>V-Ha-Ras Harvey Rat Sarcoma</italic> (<italic>HRAS)</italic> gene is one of the most frequently mutated genes in cancer. <italic>HRAS</italic> shares more than 95% of similarity with the corresponding gene in medaka [<xref ref-type="bibr" rid="B12-ijms-19-03929">12</xref>]. In biomedical research, fish has important advantages over other animal models, such as easy to breed, and able to be raised in a large number at relatively low cost. However, some aspects may diverge, such as the evolution of human chromosome 17 mapped to zebrafish Linkage group (LG) 3, 5, 12, and 15, which suggests an ancestral rearrangement [<xref ref-type="bibr" rid="B13-ijms-19-03929">13</xref>]. Another key feature of using the fish is to combine developmental biology with the power of genetics, whereby transgenic lines can produce insightful results. Moreover, it is also feasible to perform high-throughput approaches in fish models, such as whole genome mutagenesis and chemical library drug screening [<xref ref-type="bibr" rid="B14-ijms-19-03929">14</xref>,<xref ref-type="bibr" rid="B15-ijms-19-03929">15</xref>]. </p>
</sec>
<sec id="sec2-ijms-19-03929">
<title>2. Teleost Models for Melanoma Studies</title>
<p>In the past decades, several fish models have been established and transgenic lines have proven the idea that fish species are valuable in cancer research [<xref ref-type="bibr" rid="B16-ijms-19-03929">16</xref>,<xref ref-type="bibr" rid="B17-ijms-19-03929">17</xref>] (summarized in <xref ref-type="table" rid="ijms-19-03929-t001">Table 1</xref>). For instance, mutagenesis screenings often identify phenotypes that are severe in human disease model [<xref ref-type="bibr" rid="B18-ijms-19-03929">18</xref>,<xref ref-type="bibr" rid="B19-ijms-19-03929">19</xref>]. The uncovered mutations strongly affected the functions of the gene and caused severe phenotypes. These human diseases, which are hard to clarify through analytical experiment and far from being understood, might be better understood through the evolutionary mutant models [<xref ref-type="bibr" rid="B20-ijms-19-03929">20</xref>]. Most fish species have natural variation in genes that are corresponding to human disease, they have created genetic diversity in a similar way as in humans [<xref ref-type="bibr" rid="B19-ijms-19-03929">19</xref>]. Genomic and transcriptomic evolutionary fish models that have been fully sequenced are summarized in <xref ref-type="table" rid="ijms-19-03929-t002">Table 2</xref>. Examples of fish models for melanoma research are described in the following sections.</p>
</sec>
<sec id="sec3-ijms-19-03929">
<title>3. Zebrafish</title>
<p>In 1970s, George Streisinger introduced the zebrafish (<italic>Danio rerio</italic>) model into biomedical research laboratories. Zebrafish has been a canonical biomedical research model, which had many strains adapted for human disease studies [<xref ref-type="bibr" rid="B10-ijms-19-03929">10</xref>]. The main reasons for the versatility of zebrafish in research with numerous experimental advantages are that it is relatively easy and economical to maintain and amenable to genetic analysis [<xref ref-type="bibr" rid="B37-ijms-19-03929">37</xref>]. One of the key features of zebrafish as a disease model is having great power to perform high-throughput drug screening of chemical libraries [<xref ref-type="bibr" rid="B38-ijms-19-03929">38</xref>]. These chemical screenings using embryos that harbor several disease-related phenotypes are performed in multi-wells with tens of thousands of different compounds and can lead to the identification of promising candidate molecules [<xref ref-type="bibr" rid="B29-ijms-19-03929">29</xref>]. In addition, the zebrafish resource center ZIRC (available online: <uri xlink:href="http://zebrafish.org/zirc/home/guide.php">http://zebrafish.org/zirc/home/guide.php</uri>) has been established at the University of Oregon campus in Eugene, Oregon, USA, which provides a central repository for mutant, transgenic and wild-type zebrafish and distributes these resources to the research community. With their small size and short generation time, breeding and maintaining zebrafish is relatively simple and economical. In addition, researchers have established a detailed understanding of zebrafish biology and genetics to develop large numbers of techniques and powerful genetics tools, not yet available for larger mammals [<xref ref-type="bibr" rid="B39-ijms-19-03929">39</xref>]. </p>
<p>Many researchers have concluded that zebrafish is the best model for melanoma studies [<xref ref-type="bibr" rid="B28-ijms-19-03929">28</xref>,<xref ref-type="bibr" rid="B40-ijms-19-03929">40</xref>,<xref ref-type="bibr" rid="B41-ijms-19-03929">41</xref>]. The nodal inhibition promotes the reversion of melanoma cells towards a melanocytic phenotype [<xref ref-type="bibr" rid="B42-ijms-19-03929">42</xref>]. In addition, the nodal signaling plays a key role in melanoma cell plasticity and tumorigenicity in vivo [<xref ref-type="bibr" rid="B42-ijms-19-03929">42</xref>]. The melanin biosynthesis in vertebrates depends on the function of three enzymes of the tyrosinase family, tyrosinase (Tyr), tyrosinase related protein 1 (Tyrp1), and dopachrome tautomerase (Dct or Tyrp2). The mutations in Tyr family causes melanophore death, which leads to semi-dominant phenotype in the fish [<xref ref-type="bibr" rid="B43-ijms-19-03929">43</xref>].</p>
<p>A number of genes involved in melanoma formation in vivo have been identified [<xref ref-type="bibr" rid="B44-ijms-19-03929">44</xref>]. The common master melanocyte transcription factor microphthalmia associated transcription factor (MITF) plays an important role in vertebrate melanoma formation. The temperature sensitive <italic>mitf</italic> zebrafish mutant can conditionally control endogenous MITF activity in vivo [<xref ref-type="bibr" rid="B45-ijms-19-03929">45</xref>]. Studies have shown that low level of endogenous MITF activity is oncogenic with <italic>BRAF</italic> (V600E), which also promotes melanoma progression [<xref ref-type="bibr" rid="B45-ijms-19-03929">45</xref>,<xref ref-type="bibr" rid="B46-ijms-19-03929">46</xref>]. The increased telomerase activity causes many types of cancer in animal model [<xref ref-type="bibr" rid="B47-ijms-19-03929">47</xref>]. It is found that 50â60% of melanomas formed by sunlight (UV) exposure, which causes <italic>BRAF</italic> mutation in vivo [<xref ref-type="bibr" rid="B48-ijms-19-03929">48</xref>]. At the molecular level, there were very few differences between humans and the zebrafish genome. For example, the human <italic>BRAF</italic> gene, which is one of the most frequently mutated genes in melanoma, shares almost 96% of identity with the corresponding gene in zebrafish. Interestingly, there are very few amino acid differences in the carboxyl terminus, where the human oncogenic mutations are found<bold>.</bold> Nevertheless, many researchers have confirmed that the fish has the same histopathology of melanocyte in vivo [<xref ref-type="bibr" rid="B21-ijms-19-03929">21</xref>,<xref ref-type="bibr" rid="B49-ijms-19-03929">49</xref>]. The transgenic and gene knockout fish can be generated with appropriate techniques, such as through Tol2 transposon-mediated transgenesis and TALENs/Crispr-Cas9 mediated genome editing tools [<xref ref-type="bibr" rid="B50-ijms-19-03929">50</xref>,<xref ref-type="bibr" rid="B51-ijms-19-03929">51</xref>].</p>
</sec>
<sec id="sec4-ijms-19-03929">
<title>4. Downstream Signaling in BRAF/Mitogen-activated protein (MAP) Kinase Pathway</title>
<p>Both BRAF <sup>V600E</sup> and mutant p53 expressed in melanocytes may not always lead to melanoma in humans. However, the mutation in BRAF <sup>V600E</sup> protein results in a 700-fold increase of kinase activity over the wild-type BRAF [<xref ref-type="bibr" rid="B52-ijms-19-03929">52</xref>]. Genotype specific amplification of protein kinase A that co-operates with BRAF and p53 mutation is suggested to be involved in melanogenesis [<xref ref-type="bibr" rid="B21-ijms-19-03929">21</xref>,<xref ref-type="bibr" rid="B53-ijms-19-03929">53</xref>]. The BRAF and NRAS mutations are mutually exclusive in melanomas, suggesting that mutation in single gene locus is enough to over-activate the downstream Extracellular signal-regulated kinase (ERK) pathway [<xref ref-type="bibr" rid="B54-ijms-19-03929">54</xref>]. MITF is amplified in a subset of human melanomas, which cooperates with oncogenic BRAF <sup>V600E</sup> to transform normal melanocytes [<xref ref-type="bibr" rid="B55-ijms-19-03929">55</xref>]. Mitf-dependent transcription is essential for melanocyte development and pigmentation. Disruption of Mitf in melanocyte or melanoma triggers profound apoptosis and is susceptible to rescue by B-cell lymphoma 2 (BCL2) overexpression [<xref ref-type="bibr" rid="B56-ijms-19-03929">56</xref>]. Clinically, primary human melanoma expression microarrays reveals tight linkage between MITF and BCL2 [<xref ref-type="bibr" rid="B57-ijms-19-03929">57</xref>]. Mitf is a Cyclin-dependent kinase inhibitor gene that acts as an anti-proliferative transcription factor to induce G1 arrest in the cell cycle. Moreover, cooperation between Mitf and the retinoblastoma protein Retinoblastoma 1 (Rb1) potentiates Mitf to activate transcription, which leads to dysregulation of the cell cycle and causes melanoma in humans [<xref ref-type="bibr" rid="B56-ijms-19-03929">56</xref>]. Approximately 60% of melanomas were caused by mutations in the <italic>BRAF</italic> gene and resulted in an alteration of BRAF protein expression that leads to the activation of downstream signaling in the MAP kinase pathway [<xref ref-type="bibr" rid="B58-ijms-19-03929">58</xref>]. Moreover, in 90% of the cases, the activating mutations contain the substitution of glutamic acid to valine at amino acid position 600 of the <italic>BRAF</italic> protein [<xref ref-type="bibr" rid="B59-ijms-19-03929">59</xref>]. In 2011, Long and colleagues found that <italic>BRAF</italic> mutations were related to a high incidence of melanoma, including earlier age of onset, shortened survival, and lack of chronic skin damage, suggesting the importance of inhibiting mutated <italic>BRAF</italic> in a population of 197 patients [<xref ref-type="bibr" rid="B60-ijms-19-03929">60</xref>]. Up to 25% of melanomas are associated with p53 mutations, based on studies in a zebrafish model [<xref ref-type="bibr" rid="B61-ijms-19-03929">61</xref>]. The researchers confirmed that the ADP Ribosylation factor (ARF) deficiency leading to negative impacts on p53 activity causes melanoma in fish, as well as in humans [<xref ref-type="bibr" rid="B61-ijms-19-03929">61</xref>,<xref ref-type="bibr" rid="B62-ijms-19-03929">62</xref>]. It has been shown that the Telomerase reverse transcriptase (TERT) mutations caused cutaneous cancer in the animal body. The BRAF <sup>V600E</sup>/p53-transgenic melanoma model in the telomerase mutant unequivocally illustrated the importance of telomere lengthening mechanisms in proliferation-associated diseases in human and zebrafish [<xref ref-type="bibr" rid="B63-ijms-19-03929">63</xref>].</p>
<p>Both BRAF and NRAS proteins have a significant role in a pathway called ERK or Mitogen-activated protein kinase (MAPK). These proteins are part of a mechanism that turn each protein âoffâ and âonâ keeping cell proliferation under control [<xref ref-type="bibr" rid="B52-ijms-19-03929">52</xref>]. Vemurafenib, the first targeted inhibitor for the BRAF mutant has been developed and approved for the treatment options for BRAF mutated metastatic melanoma. Later, in addition to vemurafenib, several selective inhibitors targeting the BRAF and MAPK pathway have been developed with promising clinical efficacies [<xref ref-type="bibr" rid="B64-ijms-19-03929">64</xref>]. Dabrafenib and Encorafenib are the two inhibitors used to block the BRAF mutation. <xref ref-type="fig" rid="ijms-19-03929-f001">Figure 1</xref> illustrates how the signaling pathways triggered by the binding of growth factors that triggers RAS/MAPK pathways leads to cell growth and proliferation.</p>
<p>In the last few years, the use of zebrafish model system with the advent and validation of morpholinos, as well as the increasing efficiency of transgenic techniques, has made it possible to study the effects of tens, or even hundreds of genes on specific phenotypes [<xref ref-type="bibr" rid="B65-ijms-19-03929">65</xref>]. Specific networks, derived from the integration of expression profiling data or genetic screens in lower organisms can be validated efficiently. In addition, new hypotheses on network structure in cognate vertebrate phenotypes can be explored efficiently. Therefore, zebrafish offered a middle ground, with robust modeling of complex vertebrate biology and accessibility to functional genomics in different tissues or organs. Nonetheless, with the scalability necessary for rigorous geneâgene and geneâenvironment analyses, it facilitates the parallel exploration of all loci for the trait in question [<xref ref-type="bibr" rid="B66-ijms-19-03929">66</xref>]. In a recent study, transgenic zebrafish harboring tissue-specific oncogenic alleles of human <italic>BRAF</italic> and <italic>NRAS</italic> downstream to a melanocyte-specific (<italic>mitf</italic>) promoter were used to manipulate zebrafish melanomas to determine the spectrum of mutations in the absence of UV light and to interrogate the role of <italic>BRAF</italic>, <italic>NRAS</italic> and <italic>p53</italic> in melanoma in transgenic zebrafish [<xref ref-type="bibr" rid="B22-ijms-19-03929">22</xref>]. The results revealed that the Histone-lysine N-methyltransferase SETDB1 (SETDB1) is present in the zebrafish. SETDB1 methylates histone H3 on lysine 9 (H3K9) to accelerate melanoma formation significantly in zebrafish [<xref ref-type="bibr" rid="B67-ijms-19-03929">67</xref>]. SETDB1 is an oncogene in melanoma and underscores the role of chromatin factors in tumorigenesis [<xref ref-type="bibr" rid="B68-ijms-19-03929">68</xref>]. The other two histone methyltransferases (HMTs), SETDB1 and Histone-lysine N-methyltransferase SUV39H1 (SUV39H1), also cooperate with BRAF <sup>V600E</sup> to accelerate the incidence and severity of melanoma development in fish [<xref ref-type="bibr" rid="B69-ijms-19-03929">69</xref>]. Studies shows that C-X-C motif chemokine ligand 8 (CXCL8) chemokine played an important role in B-cell lymphoma-extra large (BCL-XL) protein overexpression during tumor progression of human melanoma cells in a zebrafish xenograft model [<xref ref-type="bibr" rid="B49-ijms-19-03929">49</xref>,<xref ref-type="bibr" rid="B70-ijms-19-03929">70</xref>]. The transient receptor potential melastatin 7 (TRPM7) is a nonselective cation channel, which is involved in the regulation of melanocyte growth, spreading, and survival. Generally, TRPM1 and TRPM7 are expressed in human melanoma cell lines, and they are also found in zebrafish [<xref ref-type="bibr" rid="B71-ijms-19-03929">71</xref>]. The transgenic and knockout technologies for zebrafish are well established and allow for rapid analysis of the huge amount of data related to human cancer studies. Various labs all over the world demonstrated the potential use of fish model to study functional genomics in cancer [<xref ref-type="bibr" rid="B72-ijms-19-03929">72</xref>,<xref ref-type="bibr" rid="B73-ijms-19-03929">73</xref>,<xref ref-type="bibr" rid="B74-ijms-19-03929">74</xref>]. In contrast to the other models, such as mice and fly, zebrafish is unique in that its tumors biologically and morphologically mirror tumors in humans. Therefore, studying tumor microenvironment in the zebrafish model will further our understanding of cancer development.</p>
</sec>
<sec id="sec5-ijms-19-03929">
<title>5. Non-Melanoma Skin Cancer Pathogenesis in Zebrafish Model</title>
<p>In addition to being a valuable model in melanoma research, the fish is also a good model to study the formation and mechanisms of non-melanoma skin cancer. The fish skin model of multistage carcinogenesis continues to be a major in vivo model for studying constant and stepwise evolution of the cancer process. The initiation phase of skin carcinogenesis is facile in a teleost that involves genetic damage in forms of DNA adducts or initiator-induced DNA base changes. Compared to melanoma model, the non-melanoma skin cancer formation in fish is less reported. Scientists co-expressed active human RAC-alpha serine/threonine-protein kinase 1 (AKT1) with zebrafish smoa1-Enhanced green fluorescent protein (EGFP) fusion protein in skin and this resulted in several non-skin tumor types formation including rhabdomyoma, ocular melanoma, astrocytoma and spindle cell sarcoma [<xref ref-type="bibr" rid="B75-ijms-19-03929">75</xref>]. Those studies suggested the oncogenic transformation threshold of the fish skin might be higher than other tissues. A group of Taiwanese scientists tried to establish a novel non-melanoma skin model in zebrafish to elucidate its role in tumorigenesis. By using Tol2 transposon, they created a transgenic zebrafish model in which different oncogene co-activation was expressed under a skin-specific <italic>krt4</italic> promoter [<xref ref-type="bibr" rid="B30-ijms-19-03929">30</xref>]. They reported any single activation of either c-myc or cdc6 was unable to induce an oncogenic transformation in zebrafish skin. However, co-overexpression of transcription factor c-myc and cell cycle licensing factor cdc6 induced non-melanoma skin cancer formation at embryonic stage. This zebrafish model can be useful for initial drug screen and can also be used to predict the effects of structural modifications on chemical activity [<xref ref-type="bibr" rid="B30-ijms-19-03929">30</xref>].</p>
</sec>
<sec id="sec6-ijms-19-03929">
<title>6. Platyfish (<italic>Xiphophorus</italic> Sp.)</title>
<p>At the beginning of the nineteenth century, the first fish melanoma model was established in <italic>Xiphophorus.</italic> The scientific community identified that genetic hybrids between pigmented platyfish (<italic>Xiphophorus maculatus</italic>) and non-pigmented swordtails (<italic>Xiphophorus helleri</italic>) developed spontaneous melanomas from the macromelanophors [<xref ref-type="bibr" rid="B76-ijms-19-03929">76</xref>,<xref ref-type="bibr" rid="B77-ijms-19-03929">77</xref>,<xref ref-type="bibr" rid="B78-ijms-19-03929">78</xref>]. The hybrid pigments are biologically active and easily synthesized in vivo [<xref ref-type="bibr" rid="B79-ijms-19-03929">79</xref>,<xref ref-type="bibr" rid="B80-ijms-19-03929">80</xref>]. It was considered as a true evolutionary mutant model because the malignant skin cancers developed from naturally occurring large pigment spots that were found in several fish species with a function of kin recognition and mate choice [<xref ref-type="bibr" rid="B81-ijms-19-03929">81</xref>]. This model was soon developed ahead of all the other evolutionary models because it offered various powerful laboratory tools [<xref ref-type="bibr" rid="B81-ijms-19-03929">81</xref>]. The genome of platyfish was completed sequenced in 2013 and available to the public in the ENSEMBL genome server (available online: <uri xlink:href="http://uswest.ensembl.org/Xiphophorus_maculatus/Info/Index">http://uswest.ensembl.org/Xiphophorus_maculatus/Info/Index</uri>). Fish cell lines have been established in a genetic stock center at the University of San Marcos (available online: <uri xlink:href="http://www.xiphophorus.txstate.edu/">http://www.xiphophorus.txstate.edu/</uri>), where inbred lines and strains derived from natural populations, as well, comprehensive information on protocols, genetic maps and referral databases are provided [<xref ref-type="bibr" rid="B82-ijms-19-03929">82</xref>]. </p>
<p>Dr. Wakamatsu has established a fish melanoma cell line named PSM1 from <italic>Xiphophorus sp</italic>, which can grow randomly without contact inhibition and form many clumps in vitro. High tyrosinase activity and 2-day doubling time were detected in PSM1 cell lines [<xref ref-type="bibr" rid="B83-ijms-19-03929">83</xref>]. The histopathological analysis of malignant melanomas in the <italic>Xiphophorus</italic> and humans reflected the same biological phenomenon [<xref ref-type="bibr" rid="B84-ijms-19-03929">84</xref>,<xref ref-type="bibr" rid="B85-ijms-19-03929">85</xref>,<xref ref-type="bibr" rid="B86-ijms-19-03929">86</xref>]. The cell lines generated from interspecific hybrids between <italic>Xiphophorus maculatus</italic> and <italic>Xiphophorus helleri</italic> have been used to evaluate the ultrastructure of pigment cells, tyrosinase activity, and the 3, 4-deoxyphenylalanine (DOPA) combined pre-melanin reactions [<xref ref-type="bibr" rid="B87-ijms-19-03929">87</xref>]. Signaling cascades, such as the RAS/RAF/ERK1/2 pathway, the PI3K/AKT pathway, Ras-related C3 botulinum toxin substrate 1 (RAC1) and Nuclear factor kappa-light-chain-enhancer of activated B cells (NFÎºB)-associated pathway are involved in melanoma initiation and progression in vivo [<xref ref-type="bibr" rid="B88-ijms-19-03929">88</xref>].</p>
<p>Several studies suggested that 90% of cutaneous melanoma and somatic mutations were caused by DNA damage through the exposure to UV light [<xref ref-type="bibr" rid="B89-ijms-19-03929">89</xref>,<xref ref-type="bibr" rid="B90-ijms-19-03929">90</xref>]. The histopathological and genetic characteristics of melanomas induced by N-methyl-N-nitrosourea (MNU) or UV radiation help to classify various types of melanoma including (i) melanocytic melanomas, (ii) melanophorous- macromelanophorous polymorphic melanomas, (iii) spindle cell type melanomas, (iv) epithelioid cell melanomas and (v) amelanotic melanomas in vivo [<xref ref-type="bibr" rid="B86-ijms-19-03929">86</xref>]. In the case of cross and backcross, both <italic>Xiphophorus maculatus</italic> and <italic>Xiphophorus helleri</italic> showed susceptibility to developing invasive melanoma by the radiation exposure and confirmed that fish can provide similar aspects to mammalian melanoma in vivo [<xref ref-type="bibr" rid="B91-ijms-19-03929">91</xref>,<xref ref-type="bibr" rid="B92-ijms-19-03929">92</xref>].</p>
<p>In fish <italic>Xiphophorus</italic>, melanomas are initiated by various signaling pathways that govern tumor growth and progression [<xref ref-type="bibr" rid="B80-ijms-19-03929">80</xref>,<xref ref-type="bibr" rid="B93-ijms-19-03929">93</xref>,<xref ref-type="bibr" rid="B94-ijms-19-03929">94</xref>]. Many genes important to melanoma induction, transformation, and metastasis have been identified. The alterations in oncogenes or tumor suppressor genes (<italic>CDKN2A</italic>, <italic>RB1</italic>, <italic>Xmrk</italic>, <italic>Tu</italic>, <italic>PTEN</italic>, <italic>P53</italic>) can lead to various carcinogenesis within skin [<xref ref-type="bibr" rid="B16-ijms-19-03929">16</xref>,<xref ref-type="bibr" rid="B95-ijms-19-03929">95</xref>,<xref ref-type="bibr" rid="B96-ijms-19-03929">96</xref>,<xref ref-type="bibr" rid="B97-ijms-19-03929">97</xref>]. Overexpression, duplication, or deletion of these genes can cause melanoma in fish [<xref ref-type="bibr" rid="B98-ijms-19-03929">98</xref>,<xref ref-type="bibr" rid="B99-ijms-19-03929">99</xref>]. On the other hand, specific compounds and nucleotides also can regulate the melanophore content in the animal body. For instance, the epinephrine causes pigment aggregation and alters the cyclic adenosine monophosphate (cAMP) content in the cells. The centrifugal and centripetal translocations of melanosomes within melanophores are regulated by the intracellular concentration of cyclic AMP in the body [<xref ref-type="bibr" rid="B100-ijms-19-03929">100</xref>].</p>
<p>Kazianis et al. reported that the melanoma tumor suppressor function of controlling R-<italic>Diff</italic> linkage group of <italic>Xiphophorus</italic> fish model has structural similarity with the <italic>Cyclin-dependent kinase inhibitor 2A</italic> (<italic>CDKN2)</italic> gene in human [<xref ref-type="bibr" rid="B96-ijms-19-03929">96</xref>]. The well-studied oncogenic <italic>Xiphophorus</italic> melanoma receptor kinase (Xmrk), has been characterized at the molecular level [<xref ref-type="bibr" rid="B101-ijms-19-03929">101</xref>]. This gene loci is involved in sexual maturity, pigmentation, and melanoma formation in the fish [<xref ref-type="bibr" rid="B102-ijms-19-03929">102</xref>,<xref ref-type="bibr" rid="B103-ijms-19-03929">103</xref>]. The Xmrk receptor is constitutively activated with the presence of high levels of receptor molecules containing two activating mutations. These mutations are located in the extracellular domain of the receptor, and both activated <italic>Xmrk</italic> through the formation of disulfide-linked dimers [<xref ref-type="bibr" rid="B104-ijms-19-03929">104</xref>]. The hypomethylation of <italic>Xmrk</italic> oncogenic promoter was analyzed in the <italic>Xiphophorus</italic> fish melanoma cell line PSM1 leading to overexpression of the <italic>Xmrk</italic> oncogene which caused melanoma in platyfish in vivo [<xref ref-type="bibr" rid="B105-ijms-19-03929">105</xref>]. The microphthalmia associated transcription factor (MITF) is the main regulator of melanocyte specific gene expression, which is also involved in tyrosinase gene regulation and plays a major role in melanin synthesis pathway. The <italic>Xmrk</italic> suppresses the differentiation signals relayed by MITF as part of the transformation process leading to melanoma formation in the teleost [<xref ref-type="bibr" rid="B106-ijms-19-03929">106</xref>]. Many studies have shown that this sex-linked oncogene, <italic>Xmrk</italic>, and an autosomal tumor suppressor gene, <italic>Diff,</italic> have various influences in melanoma [<xref ref-type="bibr" rid="B96-ijms-19-03929">96</xref>]. <italic>Xmrk</italic> plays a major role in the formation of the pigmentation pattern in the cells; whereas <italic>Diff</italic> regulates proliferation in melanoma cells [<xref ref-type="bibr" rid="B107-ijms-19-03929">107</xref>]. The esterase locus, <italic>Est1</italic>, is linked to the autosomal regulatory gene <italic>Diff</italic>, which controls differentiation of melanoma cells in the <italic>Xiphophorus</italic>. <italic>Est1</italic> locus provides a marker for monitoring the presence of the <italic>Diff</italic> autosome in vivo [<xref ref-type="bibr" rid="B108-ijms-19-03929">108</xref>]. <italic>Xmrk</italic> oncogene encodes the receptor of tyrosine kinase related to epidermal growth factor receptor (EGFR) <italic>in vivo</italic> [<xref ref-type="bibr" rid="B98-ijms-19-03929">98</xref>,<xref ref-type="bibr" rid="B109-ijms-19-03929">109</xref>]. The melanoma-inducing EGFR-related receptor, Xmrk, specifically induces constitutive activation of Signal transducer and activator transcription 5 (STAT5) in fish melanoma cells. The direct interaction of the receptor kinase domain with the STAT protein in a phosphotyrosine-independent way led to activation of STAT5 in terms of DNA binding and target gene expression in fish [<xref ref-type="bibr" rid="B110-ijms-19-03929">110</xref>]. The other two STAT factors, STAT1 and STAT3, implied in signaling by the Xmrk-related EGF receptor are not activated in this particular <italic>Xiphophorus</italic> melanoma cell type. Therefore, Xmrk initiates very specific signaling pathways and transcriptional responses in <italic>Xiphophorus</italic> melanoma [<xref ref-type="bibr" rid="B111-ijms-19-03929">111</xref>]. The oncogenic EGFR variant of Xmrk induces the motility of melanocytes by interacting with focal adhesion kinase (FAK), which results in the malignant transformation of pigment cells in the system [<xref ref-type="bibr" rid="B112-ijms-19-03929">112</xref>]. Genetic evaluation showed that the Sarcoma oncogene (src) family Src-homology 2 (SH2) domain interactions in the intracellular signaling of Xmrk have a binding affinity to the ubiquitous general receptor tyrosine kinases (RTK) substrate in fish [<xref ref-type="bibr" rid="B113-ijms-19-03929">113</xref>]. The phosphatidylinositol 3 kinase (PI3kinase) is a substrate of Xmrk receptor, which plays a significant role in mitogenic signaling of PSM melanoma cells and the formation of malignant melanoma in <italic>Xiphophorus</italic> species [<xref ref-type="bibr" rid="B114-ijms-19-03929">114</xref>]. The requirements for cooperating mutations have been confirmed in melanoma models listed in <xref ref-type="table" rid="ijms-19-03929-t001">Table 1</xref>.</p>
</sec>
<sec id="sec7-ijms-19-03929">
<title>7. Medaka (<italic>Oryzias latipes</italic>)</title>
<p>Medaka is a small fresh water fish that is native to Taiwan, Japan, Korea and China. The life span of medaka in the laboratory is about 12 months and can be extended to more than 2 years. It has been widely used as a genetic model in various fields including genetics, developmental biology, evolution, and toxicology [<xref ref-type="bibr" rid="B115-ijms-19-03929">115</xref>]. Medaka has helped to reveal many biological pathways of melanoma in vivo. The N-Methyl-N-nitro-N-nitrosoguanidine (MNNG) can induce melanoma in different strains of medaka (H04C and HB32C) [<xref ref-type="bibr" rid="B115-ijms-19-03929">115</xref>,<xref ref-type="bibr" rid="B116-ijms-19-03929">116</xref>,<xref ref-type="bibr" rid="B117-ijms-19-03929">117</xref>]. To identify and decipher molecular mechanisms underlying melanoma, established medaka melanoma cells stably expressing Green fluorescence protein (GFP) have been transplanted into UV-irradiated and non-irradiated medaka, respectively. This medaka model provided an opportunity to visualize in vivo tumor cells within animal model [<xref ref-type="bibr" rid="B72-ijms-19-03929">72</xref>]. The UV light causes alteration and progression of melanocyte resulting in melanoma or other skin-related symptoms. Studies showed that no effect of UV irradiation was observed on the expression of p53 in cell culture as well as in fish body; however, Ultraviolet-B (UV-B) radiation caused DNA damage and histological changes in the fish [<xref ref-type="bibr" rid="B118-ijms-19-03929">118</xref>,<xref ref-type="bibr" rid="B119-ijms-19-03929">119</xref>]. Abnormal expression of piwi interacting RNAs (piRNAs) also has been reported to associate with melanoma pathogenesis in both medaka and <italic>Xiphophorus</italic> fishes [<xref ref-type="bibr" rid="B120-ijms-19-03929">120</xref>].</p>
<p>The oncogenic receptor tyrosine kinase, <italic>Xmrk</italic> is responsible for melanoma formation in vertebrates. The <italic>Stat5</italic> activation, <italic>Mitf</italic> (microphthalmia associated transcription factor) and <italic>Bcl2</italic> levels are correlated with the aggressive stage of the malignancy in the pigment cells [<xref ref-type="bibr" rid="B121-ijms-19-03929">121</xref>,<xref ref-type="bibr" rid="B122-ijms-19-03929">122</xref>]. The Xmrk is an orthologue of the human epidermal growth factor receptor (EGFR) and activates several downstream signaling pathways including direct phosphorylation of BRAF and Stat5<italic>,</italic> as well as the enhanced transcription of c-myc. The researchers analyzed the BRAF, Stat5 and c-myc in the medaka and confirmed that the protein motifs are highly conserved among vertebrates [<xref ref-type="bibr" rid="B123-ijms-19-03929">123</xref>]. These results indicated that genetic factors are involved in <italic>Xmrk</italic> driven melanoma formation [<xref ref-type="bibr" rid="B123-ijms-19-03929">123</xref>]. The transgenic medaka has been established as an in vivo model system for screening anticancer drugs [<xref ref-type="bibr" rid="B124-ijms-19-03929">124</xref>]. MicroRNAs (miRNAs), a class of small noncoding RNAs, regulate gene expression at the posttranscriptional level, and is also involved in pathways leading to melanoma. Studies showed that the transgenic melanoma model in medaka is similar to human melanoma in vivo [<xref ref-type="bibr" rid="B125-ijms-19-03929">125</xref>]. It has been shown that miR17â92 cluster (miR20a2, miR92a1, miR17 and miR18a), miR126, miR182, miR210, and miR214 are upregulated and their respective target genes (<italic>Runt-related transcription factor 1</italic> (<italic>RUNX1</italic>)<italic>; Hypoxia-inducible factor 1A</italic> (<italic>HIF1A</italic>)<italic>; TGF-beta type 1 serine/threonine kinase receptor</italic> (<italic>TGFBR2</italic>)<italic>; Thrombospodin 1</italic> (<italic>THBS1</italic>)<italic>; and Janus kinase 2</italic> (<italic>JAK2</italic>) are downregulated in both medaka and human melanoma model [<xref ref-type="bibr" rid="B126-ijms-19-03929">126</xref>]. Recently, a group in Germany examined the whole-body transcriptome response in invasive melanoma by using transcriptomic profiling to screen for drugs in a medaka model. Their results revealed a profound down-regulation of genes involving in the immune response, particularly the innate immune system. In previous studies, novel genes have not been found yet in human melanoma; however, new candidate drug targets for further testing in this malignant melanoma medaka model have been identified [<xref ref-type="bibr" rid="B8-ijms-19-03929">8</xref>].</p>
</sec>
<sec id="sec8-ijms-19-03929">
<title>8. Annual Fish or Killifish</title>
<p>Annual or killifish especially those in the genus <italic>Limnaeus</italic> is considered a popular model organism for studying cell cycle regulation [<xref ref-type="bibr" rid="B127-ijms-19-03929">127</xref>]. It has an extremely fast growth rate and completes its entire life cycle within 6 weeks, which is an ideal model for aging and longevity research [<xref ref-type="bibr" rid="B128-ijms-19-03929">128</xref>]. Killifish undergoes embryonic diapause, with embryos that can survive in dry mud for up to one year, providing a potential model for developmental diapause in vertebrates [<xref ref-type="bibr" rid="B129-ijms-19-03929">129</xref>]. The cells of these embryos can survive in both conditions, extrinsic and intrinsic, under which it would be lethal for the majority of vertebrate cells. Mechanistic studies of this system is in its early stage; however, a number of promising discoveries suggested that this system might be a fruitful avenue that could provide novel strategies to control the cell cycle in cancer [<xref ref-type="bibr" rid="B130-ijms-19-03929">130</xref>].</p>
</sec>
<sec id="sec9-ijms-19-03929">
<title>9. Rock Fish (<italic>Sebastes</italic> Sp.)</title>
<p>The rock fish is an ideal model system for understanding the mechanism that contributes to the speciation process due to its extensive diversity, which includes variation in morphology, ecology and a broad range of life spans [<xref ref-type="bibr" rid="B131-ijms-19-03929">131</xref>,<xref ref-type="bibr" rid="B132-ijms-19-03929">132</xref>,<xref ref-type="bibr" rid="B133-ijms-19-03929">133</xref>]. Chromatophoromas are common tumors of marine and fresh water fish species which show varying degrees of differentiation with respect to specific pigment cell types [<xref ref-type="bibr" rid="B134-ijms-19-03929">134</xref>]. Interestingly, many studies in rock fish revealed that pigmented cutaneous lesions are consistent with the cytology of human chromatophore hyperplasia and neoplasia [<xref ref-type="bibr" rid="B135-ijms-19-03929">135</xref>].</p>
</sec>
<sec id="sec10-ijms-19-03929">
<title>10. Guppy (<italic>Poecilia reticulata</italic>)</title>
<p>Due to its high phenotypic variation, guppy is considered one of the remarkable evolutionary and ecological model organisms [<xref ref-type="bibr" rid="B136-ijms-19-03929">136</xref>]. It was first reported by Hoffman et al. that several different sequences belonging to the middle/long-wavelength sensitive (M/L WS) and other types of opsin genes and their genetic variation existed within individuals. For more than a century, diversely colored guppy fish have attracted the attention of researchers all over the world [<xref ref-type="bibr" rid="B137-ijms-19-03929">137</xref>,<xref ref-type="bibr" rid="B138-ijms-19-03929">138</xref>]. Recently, a research group in the Max Plank Institute of Developmental Biology has identified three different pigment cell types in the skin of male guppies and revealed that at least two of the three types of pigment cells, xanthophores, melanophores, and iridophores, are responsible for each of the investigated ornamental traits [<xref ref-type="bibr" rid="B139-ijms-19-03929">139</xref>].</p>
</sec>
<sec id="sec11-ijms-19-03929">
<title>11. Limitations of Animal Models in Skin Cancer Research</title>
<sec id="sec11dot1-ijms-19-03929">
<title>11.1. Laboratory Mice</title>
<p>To understand the fundamental mechanism underpinning the carcinogenesis and to develop preventive pharmaceuticals, animal experiments are inevitable for future diagnosis and treatment of cancer. Current understanding of cancer biology is demonstrated in laboratory animals due to their inbred and genetically homogeneous status. This can be genetically manipulated, allowing tissue analysis to be carried out, and enables their use as tractable models. However, complex biological experiments are neither technically nor ethically allowed in humans. Even though the mouse has been predominantly used in research for decades, questions remains focusing on its reliability as a model for human disease [<xref ref-type="bibr" rid="B140-ijms-19-03929">140</xref>]. For instance, in the pharmaceutical industry, many drugs work very well in preclinical trials in mice, yet turn out to be ineffective when subjected to clinical trials on humans [<xref ref-type="bibr" rid="B141-ijms-19-03929">141</xref>,<xref ref-type="bibr" rid="B142-ijms-19-03929">142</xref>]. Moreover, there is a growing concern in the public that laboratory animals do not reflect relevant aspects of the human immune system, which may account for discrepancies on translating treatment from bench to bedsides [<xref ref-type="bibr" rid="B143-ijms-19-03929">143</xref>,<xref ref-type="bibr" rid="B144-ijms-19-03929">144</xref>] </p>
<p>By contrast with humans, mouse skin is devoid of epidermal melanocytes as they are occupied with the hair follicles and dermis, except within ears, tails and some of the skin on footpads. In contrast, fish melanoma model mimics the appearance of melanocytes in the human epidermis. Therefore, researchers were able to establish UVB models in hairless-breed mouse to induce papilloma, blue nevi and squamous cell carcinoma, but not melanomas [<xref ref-type="bibr" rid="B145-ijms-19-03929">145</xref>]. Studies showed that several fish species offered an excellent melanoma model with human melanocyte in the epidermis [<xref ref-type="bibr" rid="B73-ijms-19-03929">73</xref>]. Moreover, human pigment cell tumors share conserved gene expression signatures with fish [<xref ref-type="bibr" rid="B146-ijms-19-03929">146</xref>]. Transgenic rescue in knockout mouse is always time consuming, expensive and labor intensive. About 15% of knockouts are developmentally lethal (available online: <uri xlink:href="www.genome.gov/12514551">www.genome.gov/12514551</uri>). Exclusive transgenic mouse studies were carried out only in early embryonic development. With those limitations, it is very difficult to identify genetic function related to human diseases. In addition, customized knockout mice are expensive ($3000â30,000) [<xref ref-type="bibr" rid="B140-ijms-19-03929">140</xref>]. Memory CD8 T cells, which are thought to respond most immediately to infection, were scarce in laboratory mice and strikingly different from human adult memory CD8 T cells [<xref ref-type="bibr" rid="B143-ijms-19-03929">143</xref>]. In contrast, CD4 and CD8 T cells are present in zebrafish [<xref ref-type="bibr" rid="B147-ijms-19-03929">147</xref>]. The Cyclin-dependent kinase inhibitor 2A (CDKN2A) mouse model has been widely used to investigate the effect of genetic alterations in melanoma initiation, progression and metastasis [<xref ref-type="bibr" rid="B148-ijms-19-03929">148</xref>]. However, in 1996, Serrano et al. developed a mouse strain with targeted deletion of CDKN2A locus and found that these animals developed into various malignancies but not melanoma [<xref ref-type="bibr" rid="B149-ijms-19-03929">149</xref>]. Another model, Replication-Competent Avian sarcoma leucosis virus (ASLV) long terminal repeat with a Splice acceptor/Tumor Virus receptor A (RCAS/TVA) system also has limitations: it requires active dividing cells, and the integration is thought to be random, potentially affecting the expression of host genes [<xref ref-type="bibr" rid="B150-ijms-19-03929">150</xref>]. Moreover, a gene with a size over 3 kilo bases cannot be successfully delivered [<xref ref-type="bibr" rid="B151-ijms-19-03929">151</xref>]. In another study, approximately 22% of the hepatocyte growth factor/scatter factor (HGF/SF) transgenic mice developed spontaneous melanoma with a mean onset of 15 months, which does not reflect the human melanoma since they exhibited a different dermal morphology [<xref ref-type="bibr" rid="B152-ijms-19-03929">152</xref>]. Large-scale drug screening is physically prohibitive in mice. There are several significant disadvantages of in vivo mice model in metastasis process: (1) the entire process of metastasis in a mouse model takes a long period of time; (2) evaluation of the early stage of metastasis is very difficult; (3) it is impossible to terminate and dissect mice to get real-time imaging of minute tumor lesion in deep tissues; (4) immuno-deficient mice still have residual antitumor competence that could prevent metastasis; and (5) laboratory maintenance is at a high cost throughout the experiment [<xref ref-type="bibr" rid="B153-ijms-19-03929">153</xref>].</p>
</sec>
<sec id="sec11dot2-ijms-19-03929">
<title>11.2. Fruitfly (<italic>Drosophila Melanogaster</italic>) as a Model for Skin Cancer Research</title>
<p><italic>Drosophila melanogaster</italic> is the common fruit fly that is widely studied and highly tractable genetic model organism for underlying molecular mechanisms of human diseases. However, many types of human tumors cannot be reproduced in the fly model, particularly those related to specific tissues (breast, ovarian and prostate cancer). In addition, telomeric protection in <italic>Drosophila</italic> is entirely different from humans. In <italic>Drosophila,</italic> telomerase is maintained by transposition of specialized retrotransposons rather than by telomerase activity, and their stability is independent of the sequence of DNA termini [<xref ref-type="bibr" rid="B142-ijms-19-03929">142</xref>]. Furthermore, the anatomy and physiology of <italic>Drosophila</italic> are considerably diverse from those of humans and assume only partial features of human cancer.</p>
</sec>
<sec id="sec11dot3-ijms-19-03929">
<title>11.3. Teleost</title>
<p>While fish showed myriad advantages in melanoma-associated research, a viewpoint related to their post-genomic influence attracts great attention among scientists. Natural environmental impacts can also deeply diverse a phenotype, which may impede upon observation [<xref ref-type="bibr" rid="B154-ijms-19-03929">154</xref>]. In addition, a laboratory-adjusted model system may also dilute the subtle phenomenon that plays an important role on genetic diseases [<xref ref-type="bibr" rid="B12-ijms-19-03929">12</xref>]. Therefore, stringent and standardized laboratory protocol needs to be established to optimize the teleost model [<xref ref-type="bibr" rid="B155-ijms-19-03929">155</xref>]. </p>
</sec>
</sec>
<sec id="sec12-ijms-19-03929">
<title>12. Cutting Edge Methods to Boost Skin Cancer Studies in Fish</title>
<p>In the last couple of years, the development of new sequencing technologies has enabled the rapid and cost-effective sequencing of whole genomes. By using the next-generation sequencing (NGS) methods, zebrafish mutants are now able to be mapped in weeks at less costs [<xref ref-type="bibr" rid="B11-ijms-19-03929">11</xref>]. Whole genome sequencing (WGS) showed the potential to speed up the process of mutation detection in zebrafish. Moreover, websites Annovar (available online: <uri xlink:href="http://www.openbioinformatics.org/annovar/">http://www.openbioinformatics.org/annovar/</uri>) and Ensemble (available online: <uri xlink:href="http://useast.ensembl.org/info/data/ftp/index.html">http://useast.ensembl.org/info/data/ftp/index.html</uri>) provide plenty of information that facilitates great progression in zebrafish-associated analyses. Genetic editing methods such as TALEN (transcription activator-like effector nucleases) and CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats) technologies are also becoming increasingly popular in generating sequence-specific knockout or knock-in gene mutations [<xref ref-type="bibr" rid="B156-ijms-19-03929">156</xref>,<xref ref-type="bibr" rid="B157-ijms-19-03929">157</xref>]. TALEN for instance comprise of both TALE DNA binding domain and Fok1 cleavage domain that function to induce DNA double strand breaks at targeted sites, the breaks are then repaired through homologous or nonhomologous end-joining (NHEJ) recombination [<xref ref-type="bibr" rid="B50-ijms-19-03929">50</xref>]. Several studies have shown a successful disruption of targeted endogenous genes in zebrafish via TALEN technology [<xref ref-type="bibr" rid="B158-ijms-19-03929">158</xref>,<xref ref-type="bibr" rid="B159-ijms-19-03929">159</xref>]. For example, Huang and colleagues targeted <italic>tnikb</italic> and <italic>dip2a</italic> genes that are highly expressed during embryonic developmental stage, and they were also one of the first group to demonstrate heritable TALEN-induced mutations in zebrafish [<xref ref-type="bibr" rid="B160-ijms-19-03929">160</xref>]. Perles et al. used zebrafish to study the effect of Matrix metalloproteinase-21 (MMP21) knockout and implicated a role for MMP21 in cardiac defects and alteration of Notch signaling, which leads to asymmetric organ development [<xref ref-type="bibr" rid="B161-ijms-19-03929">161</xref>]. Although non-viral delivery of CRISPR-Cas 9 to cells or tissues remains a key challenge, Wang and his colleagues utilized a new strategy to treat melanoma by designing single guide RNA (sgRNA) targeting Polo-like kinase-1 (PLK1) by a nano-carrier with a core of gold nanoclusters into the cell nuclei [<xref ref-type="bibr" rid="B162-ijms-19-03929">162</xref>]. The genome editing system has had a great impact in cancer research, as it allows tissue-specific modelling of human cancer, particularly melanoma [<xref ref-type="bibr" rid="B163-ijms-19-03929">163</xref>,<xref ref-type="bibr" rid="B164-ijms-19-03929">164</xref>,<xref ref-type="bibr" rid="B165-ijms-19-03929">165</xref>]</p>
</sec>
<sec id="sec13-ijms-19-03929">
<title>13. Small Molecule and Drug Screening in Zebrafish</title>
<p>A unique and efficient feature of the zebrafish is the potential to treat the whole organism with a drug by administering chemical compounds to the water. Although, differences in pharmacological effects between humans and zebrafish do exist, there are now hundreds of examples of small molecule screening that have conserved biological activities in humans and fish [<xref ref-type="bibr" rid="B166-ijms-19-03929">166</xref>,<xref ref-type="bibr" rid="B167-ijms-19-03929">167</xref>,<xref ref-type="bibr" rid="B168-ijms-19-03929">168</xref>]. Previous studies revealed that mitf is a potential therapeutic target for skin cancer treatment [<xref ref-type="bibr" rid="B55-ijms-19-03929">55</xref>,<xref ref-type="bibr" rid="B169-ijms-19-03929">169</xref>]. Cheng and colleagues designed a screen of small molecule library containing 2000 compounds, and identified SKLB226 as a suppressor of mitf expression that inhibits the viability and migration of melanoma cells [<xref ref-type="bibr" rid="B170-ijms-19-03929">170</xref>,<xref ref-type="bibr" rid="B171-ijms-19-03929">171</xref>]. A well-known mammalian target of rapamycin (mTOR) inhibitor, rapamycin, is considered as one of the potential drugs in the field and might improve access to the kinase active site of ATP competitive inhibitors [<xref ref-type="bibr" rid="B172-ijms-19-03929">172</xref>]. Tan et al. identified that HEXIM1 (hexamethylene bisacetamide inducible 1) knockdown by morpholino injection partially rescued <italic>crestin</italic> and <italic>mitfa</italic> expression in leflunomide (lef) treated zebrafish embryos [<xref ref-type="bibr" rid="B173-ijms-19-03929">173</xref>]. The efficacy of cocktails of inhibitors observed by HTS (high through-put screening) in vitro, and a drug screen using rapamycin analogs combined with PIK3K/mTORi or MEKi, are currently under clinical trials [<xref ref-type="bibr" rid="B174-ijms-19-03929">174</xref>].</p>
</sec>
<sec id="sec14-ijms-19-03929">
<title>14. Research is Changing in Advanced Melanoma (Stage III) Treatment</title>
<p>Recently, a controlled phase 2 trial study in which patients received neo-adjuvant therapy (given a cancer drug before surgery) to cure melanoma. Surprisingly 58% of the subjects had a complete pathologic response. The key factor of this new treatment is the <italic>BRAF</italic> gene mutation which present approximately 60% in melanoma patients and targeting <italic>BRAF</italic> gene with medication works in more than 90% of the cases [<xref ref-type="bibr" rid="B175-ijms-19-03929">175</xref>]. Their randomized phase 2 study reveals the high-risk resectable melanoma in 23 patients with neoadjuvant nivolumb verses combined ipilimumb with nivolumab. However, treatment with combined nivolumab and ipilimumab resulted in high response rates (73%) whereas treatment with nivolumab alone yielded modest responses (25%).</p>
</sec>
<sec id="sec15-ijms-19-03929">
<title>15. Injections of Modified Herpes Virus Kills Cancer Cells</title>
<p>A new era of combination therapy for metastatic melanoma is now on the way. Kaufman and his colleagues demonstrated that T-VEC (Talimogen laherparepvec) is the first oncolytic virus therapy that has been effective for melanoma in a phase III clinical trial [<xref ref-type="bibr" rid="B176-ijms-19-03929">176</xref>]. In that phase III trial, about 436 patients were randomly assigned and the overall response rate was higher in the T-VEC arm (26.4%) and resulted in a very high durabale response rate DRR (<italic>p</italic> &lt; 0.001).</p>
</sec>
<sec id="sec16-ijms-19-03929">
<title>16. Summarizing Remarks</title>
<p>The complexity of melanoma has been well demonstrated in teleost models, which are now providing better insights to the histopathology and pathobiology of skin cancer. Regarding melanoma initiation, development and distribution, current studies suggest that fish is the best genetic as well as drug-screening model for skin cancer, particularly melanoma [<xref ref-type="bibr" rid="B16-ijms-19-03929">16</xref>,<xref ref-type="bibr" rid="B86-ijms-19-03929">86</xref>,<xref ref-type="bibr" rid="B177-ijms-19-03929">177</xref>,<xref ref-type="bibr" rid="B178-ijms-19-03929">178</xref>]. In recent years, zebrafish has become a widely used versatile model for human diseases. It has been demonstrated the zebrafish can be used as a platform for extending our understanding of molecular and cellular mechanisms, as well as develop new diagnostic and therapeutic tools. Indeed, 70% of zebrafish genes are conserved in humans, making zebrafish ideal for studying the function of human genes in cancer, cardiovascular diseases, and complex brain disorders [<xref ref-type="bibr" rid="B25-ijms-19-03929">25</xref>,<xref ref-type="bibr" rid="B49-ijms-19-03929">49</xref>,<xref ref-type="bibr" rid="B179-ijms-19-03929">179</xref>]. </p>
<p>Currently, drug screening relies on cell-based experiments or on animal models to confirm biological effects. The mammalian system is considered too time-consuming, expensive and complex to perform high-throughput drug screening. There is a gap between in vitro cell-based models and in vivo mammalian models. The zebrafish is an ideal model that could link preclinical toxicity screening with the drug development pipeline. Taking advantage of a highly conservative genomic, rapid development, large number of offspring, low cost and easy manipulation, the zebrafish is an excellent animal model for disease-based drug screening.</p>
<p>The significant progress of current research would require a full exploration and analysis to show how close these models are to the humans, in both histological and pathological aspects. This would need more comparative studies in the laboratory. In the future, we will need to focus on developmental phenotypes and to identify the pathways involved in skin cancer. We could exploit zebrafish to understand how a compound works. For instance, by analyzing the structure and functional relationship, we may apply this information in human cells. </p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Jung-Ren Chen from I-Shou University for helping on paper English editing and proofreading.</p>
</ack>
<notes>
<title>Funding</title>
<p>This research was funded by Ministry of Science and Technology of Taiwan (grant no. MOST105-2313-B-033-001-MY3 and MOST107-2622-B-033-001-CC2) to CDH.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-ijms-19-03929">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>von MÃ¤ssenhausen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>BrÃ¤gelmann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Konantz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Queisser</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kristiansen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Duensing</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>SchrÃ¶ck</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bootz</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Targeting ddr2 in head and neck squamous cell carcinoma with dasatinib</article-title>
<source/>Int. J. Cancer
          <year>2016</year>
<volume>139</volume>
<fpage>2359</fpage>
<lpage>2369</lpage>
<pub-id pub-id-type="doi">10.1002/ijc.30279</pub-id>
<pub-id pub-id-type="pmid">27434411</pub-id>
</element-citation>
</ref>
<ref id="B2-ijms-19-03929">
<label>2.</label>
<element-citation publication-type="book">
<source/>Key Statistics for Melanoma Skin Cancer
          <publisher-name>American Cancer Society</publisher-name>
<publisher-loc>Atlanta, GA, USA</publisher-loc>
<year>2018</year>
</element-citation>
</ref>
<ref id="B3-ijms-19-03929">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Scolyer</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Kefford</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>Cutaneous melanoma</article-title>
<source/>Lancet
          <year>2005</year>
<volume>365</volume>
<fpage>687</fpage>
<lpage>701</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(05)70937-5</pub-id>
<pub-id pub-id-type="pmid">15721476</pub-id>
</element-citation>
</ref>
<ref id="B4-ijms-19-03929">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maddodi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Setaluri</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Role of uv in cutaneous melanoma</article-title>
<source/>Photochem. Photobiol.
          <year>2008</year>
<volume>84</volume>
<fpage>528</fpage>
<lpage>536</lpage>
<pub-id pub-id-type="doi">10.1111/j.1751-1097.2007.00283.x</pub-id>
<pub-id pub-id-type="pmid">18248502</pub-id>
</element-citation>
</ref>
<ref id="B5-ijms-19-03929">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilchrest</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Eller</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Geller</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Yaar</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The pathogenesis of melanoma induced by ultraviolet radiation</article-title>
<source/>N. Engl. J. Med.
          <year>1999</year>
<volume>340</volume>
<fpage>1341</fpage>
<lpage>1348</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199904293401707</pub-id>
<pub-id pub-id-type="pmid">10219070</pub-id>
</element-citation>
</ref>
<ref id="B6-ijms-19-03929">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berger</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Hodis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Heffernan</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>Deribe</surname>
<given-names>Y.L.</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Protopopov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ivanova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>I.R.</given-names>
</name>
<name>
<surname>Nickerson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Melanoma genome sequencing reveals frequent prex2 mutations</article-title>
<source/>Nature
          <year>2012</year>
<volume>485</volume>
<fpage>502</fpage>
<pub-id pub-id-type="doi">10.1038/nature11071</pub-id>
<pub-id pub-id-type="pmid">22622578</pub-id>
</element-citation>
</ref>
<ref id="B7-ijms-19-03929">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slominski</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Paus</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Bomirski melanomas-a versatile and powerful model for pigment cell and melanoma research</article-title>
<source/>Int. J. Oncol.
          <year>1993</year>
<volume>2</volume>
<fpage>221</fpage>
<lpage>228</lpage>
<pub-id pub-id-type="doi">10.3892/ijo.2.2.221</pub-id>
<pub-id pub-id-type="pmid">21573540</pub-id>
</element-citation>
</ref>
<ref id="B8-ijms-19-03929">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Maurus</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tomlinson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Postlethwait</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>W.C.</given-names>
</name>
</person-group>
<article-title>Whole body melanoma transcriptome response in medaka</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<elocation-id>e0143057</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0143057</pub-id>
<pub-id pub-id-type="pmid">26714172</pub-id>
</element-citation>
</ref>
<ref id="B9-ijms-19-03929">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plonka</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Slominski</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Pajak</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Urbanska</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Transplantable melanomas in gerbils (meriones unguiculatus). Ii: Melanogenesis</article-title>
<source/>Exp. Dermatol.
          <year>2003</year>
<volume>12</volume>
<fpage>356</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="doi">10.1034/j.1600-0625.2002.120401.x</pub-id>
<pub-id pub-id-type="pmid">12930290</pub-id>
</element-citation>
</ref>
<ref id="B10-ijms-19-03929">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patton</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Zon</surname>
<given-names>L.I.</given-names>
</name>
</person-group>
<article-title>Taking human cancer genes to the fish: A transgenic model of melanoma in zebrafish</article-title>
<source/>Zebrafish
          <year>2005</year>
<volume>1</volume>
<fpage>363</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="doi">10.1089/zeb.2005.1.363</pub-id>
<pub-id pub-id-type="pmid">18248215</pub-id>
</element-citation>
</ref>
<ref id="B11-ijms-19-03929">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Torroja</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Torrance</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Berthelot</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Muffato</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Humphray</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McLaren</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The zebrafish reference genome sequence and its relationship to the human genome</article-title>
<source/>Nature
          <year>2013</year>
<volume>496</volume>
<fpage>498</fpage>
<pub-id pub-id-type="doi">10.1038/nature12111</pub-id>
<pub-id pub-id-type="pmid">23594743</pub-id>
</element-citation>
</ref>
<ref id="B12-ijms-19-03929">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Beyond the zebrafish: Diverse fish species for modeling human disease</article-title>
<source/>Dis. Models Mech.
          <year>2014</year>
<volume>7</volume>
<fpage>181</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="doi">10.1242/dmm.012245</pub-id>
<pub-id pub-id-type="pmid">24271780</pub-id>
</element-citation>
</ref>
<ref id="B13-ijms-19-03929">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Postlethwait</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Woods</surname>
<given-names>I.G.</given-names>
</name>
<name>
<surname>Ngo-Hazelett</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Y.L.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hill-Force</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Talbot</surname>
<given-names>W.S.</given-names>
</name>
</person-group>
<article-title>Zebrafish comparative genomics and the origins of vertebrate chromosomes</article-title>
<source/>Genome Res.
          <year>2000</year>
<volume>10</volume>
<fpage>1890</fpage>
<lpage>1902</lpage>
<pub-id pub-id-type="doi">10.1101/gr.164800</pub-id>
<pub-id pub-id-type="pmid">11116085</pub-id>
</element-citation>
</ref>
<ref id="B14-ijms-19-03929">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Mulligan</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>M.-C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Scahill</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Busch-Nentwich</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Farber</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Mrna processing in mutant zebrafish lines generated by chemical and crispr-mediated mutagenesis produces unexpected transcripts that escape nonsense-mediated decay</article-title>
<source/>PLoS Genet.
          <year>2017</year>
<volume>13</volume>
<elocation-id>e1007105</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1007105</pub-id>
<pub-id pub-id-type="pmid">29161261</pub-id>
</element-citation>
</ref>
<ref id="B15-ijms-19-03929">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nikaido</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hagino-Yamagishi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Distinct functions of two olfactory marker protein genes derived from teleost-specific whole genome duplication</article-title>
<source/>BMC Evol. Biol.
          <year>2015</year>
<volume>15</volume>
<elocation-id>245</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12862-015-0530-y</pub-id>
<pub-id pub-id-type="pmid">26555542</pub-id>
</element-citation>
</ref>
<ref id="B16-ijms-19-03929">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schartl</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Malitschek</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kazianis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Borowsky</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Spontaneous melanoma formation in nonhybrid xiphophorus</article-title>
<source/>Cancer Res.
          <year>1995</year>
<volume>55</volume>
<fpage>159</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="pmid">7805027</pub-id>
</element-citation>
</ref>
<ref id="B17-ijms-19-03929">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patton</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Nairn</surname>
<given-names>R.S.</given-names>
</name>
</person-group>
<article-title>Genetic and environmental melanoma models in fish</article-title>
<source/>Pigm. Cell Melanoma Res.
          <year>2010</year>
<volume>23</volume>
<fpage>314</fpage>
<lpage>337</lpage>
<pub-id pub-id-type="doi">10.1111/j.1755-148X.2010.00693.x</pub-id>
<pub-id pub-id-type="pmid">20230482</pub-id>
</element-citation>
</ref>
<ref id="B18-ijms-19-03929">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sundberg</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Dadras</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>V.E.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Denegre</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Schofield</surname>
<given-names>P.N.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>L.E.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Wiles</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Pratt</surname>
<given-names>C.H.</given-names>
</name>
</person-group>
<article-title>Excavating the genome: Large-scale mutagenesis screening for the discovery of new mouse models</article-title>
<source/>J. Investig. Dermatol. Symp. Proc.
          <year>2015</year>
<volume>17</volume>
<fpage>27</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1038/jidsymp.2015.36</pub-id>
<pub-id pub-id-type="pmid">26551941</pub-id>
</element-citation>
</ref>
<ref id="B19-ijms-19-03929">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prykhozhij</surname>
<given-names>S.V.</given-names>
</name>
<name>
<surname>Steele</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Razaghi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Berman</surname>
<given-names>J.N.</given-names>
</name>
</person-group>
<article-title>A rapid and effective method for screening, sequencing and reporter verification of engineered frameshift mutations in zebrafish</article-title>
<source/>Dis. Model Mech.
          <year>2017</year>
<volume>10</volume>
<fpage>811</fpage>
<lpage>822</lpage>
<pub-id pub-id-type="doi">10.1242/dmm.026765</pub-id>
<pub-id pub-id-type="pmid">28280001</pub-id>
</element-citation>
</ref>
<ref id="B20-ijms-19-03929">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lenz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Karsten</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Schulz</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Voigt</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Drosophila as a screening tool to study human neurodegenerative diseases</article-title>
<source/>J. Neurochem.
          <year>2013</year>
<volume>127</volume>
<fpage>453</fpage>
<lpage>460</lpage>
<pub-id pub-id-type="doi">10.1111/jnc.12446</pub-id>
<pub-id pub-id-type="pmid">24028575</pub-id>
</element-citation>
</ref>
<ref id="B21-ijms-19-03929">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dovey</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Zon</surname>
<given-names>L.I.</given-names>
</name>
</person-group>
<article-title>Oncogenic nras cooperates with p53 loss to generate melanoma in zebrafish</article-title>
<source/>Zebrafish
          <year>2009</year>
<volume>6</volume>
<fpage>397</fpage>
<lpage>404</lpage>
<pub-id pub-id-type="doi">10.1089/zeb.2009.0606</pub-id>
<pub-id pub-id-type="pmid">19954345</pub-id>
</element-citation>
</ref>
<ref id="B22-ijms-19-03929">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Wedge</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Van Loo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>de Ridder</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Capper</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Raine</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>I.R.</given-names>
</name>
</person-group>
<article-title>The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models</article-title>
<source/>Genome Biol.
          <year>2013</year>
<volume>14</volume>
<fpage>R113</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2013-14-10-r113</pub-id>
<pub-id pub-id-type="pmid">24148783</pub-id>
</element-citation>
</ref>
<ref id="B23-ijms-19-03929">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ceol</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Houvras</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Zon</surname>
<given-names>L.I.</given-names>
</name>
</person-group>
<article-title>Melanoma biology and the promise of zebrafish</article-title>
<source/>Zebrafish
          <year>2008</year>
<volume>5</volume>
<fpage>247</fpage>
<lpage>255</lpage>
<pub-id pub-id-type="doi">10.1089/zeb.2008.0544</pub-id>
<pub-id pub-id-type="pmid">19133823</pub-id>
</element-citation>
</ref>
<ref id="B24-ijms-19-03929">
<label>24.</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>Wojciechowska</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Conditional Control of Mitf Reveals Cellular Subpopulations Essential for Melanoma Survival and Recurrence in New Zebrafish Models</article-title>
<year>2018</year>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.era.lib.ed.ac.uk/handle/1842/29645">https://www.era.lib.ed.ac.uk/handle/1842/29645</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2018-12-06">(accessed on 6 December 2018)</date-in-citation>
</element-citation>
</ref>
<ref id="B25-ijms-19-03929">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Characterization of two novel small molecules targeting melanocyte development in zebrafish embryogenesis</article-title>
<source/>Pigm. Cell Melanoma Res.
          <year>2012</year>
<volume>25</volume>
<fpage>446</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="doi">10.1111/j.1755-148X.2012.01007.x</pub-id>
<pub-id pub-id-type="pmid">22574862</pub-id>
</element-citation>
</ref>
<ref id="B26-ijms-19-03929">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kenyon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gavriouchkina</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zorman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chong-Morrison</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Napolitani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cerundolo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Sauka-Spengler</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Generation of a double binary transgenic zebrafish model to study myeloid gene regulation in response to oncogene activation in melanocytes</article-title>
<source/>Dis. Models Mech.
          <year>2018</year>
<pub-id pub-id-type="doi">10.1242/dmm.030056</pub-id>
<pub-id pub-id-type="pmid">29666124</pub-id>
</element-citation>
</ref>
<ref id="B27-ijms-19-03929">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michailidou</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kamarashev</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hurlstone</surname>
<given-names>A.F.</given-names>
</name>
</person-group>
<article-title>Dissecting the roles of raf-and pi3k-signalling pathways in melanoma formation and progression in a zebrafish model</article-title>
<source/>Dis. Models Mech.
          <year>2009</year>
<pub-id pub-id-type="doi">10.1242/dmm.001149</pub-id>
<pub-id pub-id-type="pmid">19470611</pub-id>
</element-citation>
</ref>
<ref id="B28-ijms-19-03929">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anelli</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Zettler</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mione</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Insights from genetic models of melanoma in fish</article-title>
<source/>Curr. Pathobiol. Rep.
          <year>2014</year>
<volume>2</volume>
<fpage>85</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1007/s40139-014-0043-1</pub-id>
</element-citation>
</ref>
<ref id="B29-ijms-19-03929">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santoriello</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zon</surname>
<given-names>L.I.</given-names>
</name>
</person-group>
<article-title>Hooked! Modeling human disease in zebrafish</article-title>
<source/>J. Clin. Investig.
          <year>2012</year>
<volume>122</volume>
<fpage>2337</fpage>
<lpage>2343</lpage>
<pub-id pub-id-type="doi">10.1172/JCI60434</pub-id>
<pub-id pub-id-type="pmid">22751109</pub-id>
</element-citation>
</ref>
<ref id="B30-ijms-19-03929">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.-H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>D.-S.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>C.-W.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C.-J.</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>Y.-K.</given-names>
</name>
<name>
<surname>Yen</surname>
<given-names>C.-C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A.Y.-L.</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>C.-D.</given-names>
</name>
</person-group>
<article-title>Cdc6 cooperates with c-myc to promote genome instability and epithelial to mesenchymal transition (emt) in zebrafish</article-title>
<source/>Oncotarget
          <year>2014</year>
<volume>5</volume>
<fpage>6300</fpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.2204</pub-id>
<pub-id pub-id-type="pmid">25051368</pub-id>
</element-citation>
</ref>
<ref id="B31-ijms-19-03929">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>N.R.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>L.W.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>Zebrafish as a model to investigate the effects of exercise in cancer</article-title>
<source/>bioRxiv
          <year>2018</year>
<fpage>279232</fpage>
<pub-id pub-id-type="doi">10.1101/279232</pub-id>
</element-citation>
</ref>
<ref id="B32-ijms-19-03929">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez</surname>
<given-names>A.N.</given-names>
</name>
<name>
<surname>Oehlers</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Heater</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Booth</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>W.M.</given-names>
</name>
</person-group>
<article-title>Proteomic analyses of the xiphophorus gordonâkosswig melanoma model</article-title>
<source/>Comp. Biochem. Physiol. Part C
          <year>2012</year>
<volume>155</volume>
<fpage>81</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1016/j.cbpc.2011.05.017</pub-id>
</element-citation>
</ref>
<ref id="B33-ijms-19-03929">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herrera</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jagadeeswaran</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Annual fish as a genetic model for aging</article-title>
<source/>J. Gerontol. Ser. A
          <year>2004</year>
<volume>59</volume>
<fpage>B101</fpage>
<lpage>B107</lpage>
<pub-id pub-id-type="doi">10.1093/gerona/59.2.B101</pub-id>
</element-citation>
</ref>
<ref id="B34-ijms-19-03929">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanaka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kinoshita</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nagahama</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Establishment of medaka (oryzias latipes) transgenic lines with the expression of green fluorescent protein fluorescence exclusively in germ cells: A useful model to monitor germ cells in a live vertebrate</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2001</year>
<volume>98</volume>
<fpage>2544</fpage>
<lpage>2549</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.041315498</pub-id>
<pub-id pub-id-type="pmid">11226275</pub-id>
</element-citation>
</ref>
<ref id="B35-ijms-19-03929">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandel</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Aguilar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Buonaccorsi</surname>
<given-names>V.P.</given-names>
</name>
<name>
<surname>Herstein</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Evgrafov</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Complete mitochondrial genome sequences of five rockfishes (perciformes: Sebastes)</article-title>
<source/>Mitochondrial DNA Part B
          <year>2018</year>
<volume>3</volume>
<fpage>825</fpage>
<lpage>826</lpage>
<pub-id pub-id-type="doi">10.1080/23802359.2018.1495130</pub-id>
</element-citation>
</ref>
<ref id="B36-ijms-19-03929">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>KÃ¼nstner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Kottler</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Weigel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dreyer</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The genome of the trinidadian guppy, poecilia reticulata, and variation in the guanapo population</article-title>
<source/>PLoS ONE
          <year>2016</year>
<volume>11</volume>
<elocation-id>e0169087</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0169087</pub-id>
<pub-id pub-id-type="pmid">28033408</pub-id>
</element-citation>
</ref>
<ref id="B37-ijms-19-03929">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guyon</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Steffen</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Pusack</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kunkel</surname>
<given-names>L.M.</given-names>
</name>
</person-group>
<article-title>Modeling human muscle disease in zebrafish</article-title>
<source/>Biochim. Biophys. Acta
          <year>2007</year>
<volume>1772</volume>
<fpage>205</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2006.07.003</pub-id>
<pub-id pub-id-type="pmid">16934958</pub-id>
</element-citation>
</ref>
<ref id="B38-ijms-19-03929">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rennekamp</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>R.T.</given-names>
</name>
</person-group>
<article-title>15 years of zebrafish chemical screening</article-title>
<source/>Curr. Opin. Chem. Biol.
          <year>2015</year>
<volume>24</volume>
<fpage>58</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1016/j.cbpa.2014.10.025</pub-id>
<pub-id pub-id-type="pmid">25461724</pub-id>
</element-citation>
</ref>
<ref id="B39-ijms-19-03929">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kishi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Slack</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Uchiyama</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhdanova</surname>
<given-names>I.V.</given-names>
</name>
</person-group>
<article-title>Zebrafish as a genetic model in biological and behavioral gerontology: Where development meets aging in vertebratesâA mini-review</article-title>
<source/>Gerontology
          <year>2009</year>
<volume>55</volume>
<fpage>430</fpage>
<lpage>441</lpage>
<pub-id pub-id-type="doi">10.1159/000228892</pub-id>
<pub-id pub-id-type="pmid">19654474</pub-id>
</element-citation>
</ref>
<ref id="B40-ijms-19-03929">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Zon</surname>
<given-names>L.I.</given-names>
</name>
</person-group>
<article-title>Melanocytes in development, regeneration, and cancer</article-title>
<source/>Cell Stem Cell
          <year>2008</year>
<volume>3</volume>
<fpage>242</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2008.08.005</pub-id>
<pub-id pub-id-type="pmid">18786412</pub-id>
</element-citation>
</ref>
<ref id="B41-ijms-19-03929">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaufman</surname>
<given-names>C.K.</given-names>
</name>
<name>
<surname>Mosimann</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Z.P.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Ablain</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Fogley</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>van Rooijen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hagedorn</surname>
<given-names>E.J.</given-names>
</name>
</person-group>
<article-title>A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation</article-title>
<source/>Science
          <year>2016</year>
<volume>351</volume>
<fpage>aad2197</fpage>
<pub-id pub-id-type="doi">10.1126/science.aad2197</pub-id>
<pub-id pub-id-type="pmid">26823433</pub-id>
</element-citation>
</ref>
<ref id="B42-ijms-19-03929">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Topczewska</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Postovit</surname>
<given-names>L.-M.</given-names>
</name>
<name>
<surname>Margaryan</surname>
<given-names>N.V.</given-names>
</name>
<name>
<surname>Anthony</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Wheaton</surname>
<given-names>W.W.</given-names>
</name>
<name>
<surname>Nickoloff</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Topczewski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hendrix</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Embryonic and tumorigenic pathways converge via nodal signaling: Role in melanoma aggressiveness</article-title>
<source/>Nat. Med.
          <year>2006</year>
<volume>12</volume>
<fpage>925</fpage>
<pub-id pub-id-type="doi">10.1038/nm1448</pub-id>
<pub-id pub-id-type="pmid">16892036</pub-id>
</element-citation>
</ref>
<ref id="B43-ijms-19-03929">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krauss</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Geiger-Rudolph</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>NÃ¼sslein-Volhard</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Irion</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>A dominant mutation in tyrp1a leads to melanophore death in zebrafish</article-title>
<source/>Pigm. Cell Melanoma Res.
          <year>2014</year>
<volume>27</volume>
<fpage>827</fpage>
<lpage>830</lpage>
<pub-id pub-id-type="doi">10.1111/pcmr.12272</pub-id>
<pub-id pub-id-type="pmid">24891189</pub-id>
</element-citation>
</ref>
<ref id="B44-ijms-19-03929">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Storer</surname>
<given-names>N.Y.</given-names>
</name>
<name>
<surname>Zon</surname>
<given-names>L.I.</given-names>
</name>
</person-group>
<article-title>Zebrafish models of p53 functions</article-title>
<source/>Cold Spring Harbor Perspect. Biol.
          <year>2010</year>
<volume>2</volume>
<fpage>a001123</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a001123</pub-id>
<pub-id pub-id-type="pmid">20679337</pub-id>
</element-citation>
</ref>
<ref id="B45-ijms-19-03929">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lister</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Capper</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Mathers</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Paranthaman</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>I.J.</given-names>
</name>
<name>
<surname>Patton</surname>
<given-names>E.E.</given-names>
</name>
</person-group>
<article-title>A conditional zebrafish mitf mutation reveals mitf levels are critical for melanoma promotion vs. Regression in vivo</article-title>
<source/>J. Investig. Dermatol.
          <year>2014</year>
<volume>134</volume>
<fpage>133</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1038/jid.2013.293</pub-id>
<pub-id pub-id-type="pmid">23831555</pub-id>
</element-citation>
</ref>
<ref id="B46-ijms-19-03929">
<label>46.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>White</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Zon</surname>
<given-names>L.I.</given-names>
</name>
</person-group>
<source/>Abstract Lb-335: Dhodh Regulates Transcriptional Elongation during Melanoma Evolution: Insights from Zebrafish Screening
          <publisher-name>AACR</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>2011</year>
</element-citation>
</ref>
<ref id="B47-ijms-19-03929">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinagre</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>PÃ³pulo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Batista</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lyra</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Coelho</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Celestino</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Prazeres</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Frequency of tert promoter mutations in human cancers</article-title>
<source/>Nat. Commun.
          <year>2013</year>
<volume>4</volume>
<fpage>2185</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms3185</pub-id>
<pub-id pub-id-type="pmid">23887589</pub-id>
</element-citation>
</ref>
<ref id="B48-ijms-19-03929">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flaherty</surname>
<given-names>K.T.</given-names>
</name>
<name>
<surname>Puzanov</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Ribas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McArthur</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Sosman</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Oâdwyer</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Grippo</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Nolop</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Inhibition of mutated, activated braf in metastatic melanoma</article-title>
<source/>N. Engl. J. Med.
          <year>2010</year>
<volume>363</volume>
<fpage>809</fpage>
<lpage>819</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1002011</pub-id>
<pub-id pub-id-type="pmid">20818844</pub-id>
</element-citation>
</ref>
<ref id="B49-ijms-19-03929">
<label>49.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Gabellini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>GÃ³mez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Del Bufalo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mulero</surname>
<given-names>V.</given-names>
</name>
</person-group>
<source/>Bcl-Xl Protein Overexpression Enhances Tumor Progression of Human Melanoma Cells in Zebrafish Xenograft Model: Involvement of cxcl8 Chemokine
          <publisher-name>AACR</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>2014</year>
</element-citation>
</ref>
<ref id="B50-ijms-19-03929">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joung</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Sander</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Talens: A widely applicable technology for targeted genome editing</article-title>
<source/>Nat. Rev. Mol. Cell Biol.
          <year>2013</year>
<volume>14</volume>
<fpage>49</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1038/nrm3486</pub-id>
<pub-id pub-id-type="pmid">23169466</pub-id>
</element-citation>
</ref>
<ref id="B51-ijms-19-03929">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suster</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Kikuta</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Urasaki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Asakawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kawakami</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Transgenesis in zebrafish with the tol2 transposon system</article-title>
<source/>Methods Mol. Biol.
          <year>2009</year>
<volume>561</volume>
<fpage>41</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">19504063</pub-id>
</element-citation>
</ref>
<ref id="B52-ijms-19-03929">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bignell</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stephens</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Edkins</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Clegg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Teague</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Woffendin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Garnett</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Bottomley</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Mutations of the braf gene in human cancer</article-title>
<source/>Nature
          <year>2002</year>
<volume>417</volume>
<fpage>949</fpage>
<pub-id pub-id-type="doi">10.1038/nature00766</pub-id>
<pub-id pub-id-type="pmid">12068308</pub-id>
</element-citation>
</ref>
<ref id="B53-ijms-19-03929">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Busca</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ballotti</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Cyclic amp a key messenger in the regulation of skin pigmentation</article-title>
<source/>Pigm. Cell Melanoma Res.
          <year>2000</year>
<volume>13</volume>
<fpage>60</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="doi">10.1034/j.1600-0749.2000.130203.x</pub-id>
</element-citation>
</ref>
<ref id="B54-ijms-19-03929">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goel</surname>
<given-names>V.K.</given-names>
</name>
<name>
<surname>Lazar</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Warneke</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Redston</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Haluska</surname>
<given-names>F.G.</given-names>
</name>
</person-group>
<article-title>Examination of mutations in braf, nras, and pten in primary cutaneous melanoma</article-title>
<source/>J. Investig. Dermatol.
          <year>2006</year>
<volume>126</volume>
<fpage>154</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="doi">10.1038/sj.jid.5700026</pub-id>
<pub-id pub-id-type="pmid">16417231</pub-id>
</element-citation>
</ref>
<ref id="B55-ijms-19-03929">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garraway</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Widlund</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Getz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Ramaswamy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Beroukhim</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Milner</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Granter</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Integrative genomic analyses identify mitf as a lineage survival oncogene amplified in malignant melanoma</article-title>
<source/>Nature
          <year>2005</year>
<volume>436</volume>
<fpage>117</fpage>
<pub-id pub-id-type="doi">10.1038/nature03664</pub-id>
<pub-id pub-id-type="pmid">16001072</pub-id>
</element-citation>
</ref>
<ref id="B56-ijms-19-03929">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGill</surname>
<given-names>G.G.</given-names>
</name>
<name>
<surname>Horstmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Widlund</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Motyckova</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>E.K.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.-L.</given-names>
</name>
<name>
<surname>Ramaswamy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Avery</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>H.-F.</given-names>
</name>
</person-group>
<article-title>Bcl2 regulation by the melanocyte master regulator mitf modulates lineage survival and melanoma cell viability</article-title>
<source/>Cell
          <year>2002</year>
<volume>109</volume>
<fpage>707</fpage>
<lpage>718</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(02)00762-6</pub-id>
<pub-id pub-id-type="pmid">12086670</pub-id>
</element-citation>
</ref>
<ref id="B57-ijms-19-03929">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haq</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hawryluk</surname>
<given-names>E.B.</given-names>
</name>
<name>
<surname>JÃ¶nsson</surname>
<given-names>G.B.</given-names>
</name>
<name>
<surname>Frederick</surname>
<given-names>D.T.</given-names>
</name>
<name>
<surname>McHenry</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>T.-N.</given-names>
</name>
<name>
<surname>Love</surname>
<given-names>K.T.</given-names>
</name>
<name>
<surname>Langer</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Bcl2a1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to braf inhibition</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2013</year>
<volume>110</volume>
<fpage>4321</fpage>
<lpage>4326</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1205575110</pub-id>
<pub-id pub-id-type="pmid">23447565</pub-id>
</element-citation>
</ref>
<ref id="B58-ijms-19-03929">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhomen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Marais</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Braf signaling and targeted therapies in melanoma</article-title>
<source/>Hematol. Oncol. Clin. North Am.
          <year>2009</year>
<volume>23</volume>
<fpage>529</fpage>
<lpage>545</lpage>
<pub-id pub-id-type="doi">10.1016/j.hoc.2009.04.001</pub-id>
<pub-id pub-id-type="pmid">19464601</pub-id>
</element-citation>
</ref>
<ref id="B59-ijms-19-03929">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chapman</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Hauschild</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Robert</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Haanen</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Ascierto</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Larkin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dummer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Garbe</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Testori</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Maio</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Improved survival with vemurafenib in melanoma with braf v600e mutation</article-title>
<source/>N. Engl. J. Med.
          <year>2011</year>
<volume>364</volume>
<fpage>2507</fpage>
<lpage>2516</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1103782</pub-id>
<pub-id pub-id-type="pmid">21639808</pub-id>
</element-citation>
</ref>
<ref id="B60-ijms-19-03929">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Long</surname>
<given-names>G.V.</given-names>
</name>
<name>
<surname>Menzies</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Nagrial</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Haydu</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Scolyer</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Kefford</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>Prognostic and clinicopathologic associations of oncogenic braf in metastatic melanoma</article-title>
<source/>J. Clin. Oncol.
          <year>2011</year>
<volume>29</volume>
<fpage>1239</fpage>
<lpage>1246</lpage>
<pub-id pub-id-type="doi">10.1200/JCO.2010.32.4327</pub-id>
<pub-id pub-id-type="pmid">21343559</pub-id>
</element-citation>
</ref>
<ref id="B61-ijms-19-03929">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daniotti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Oggionni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ranzani</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vallacchi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Campi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Di Stasi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Della Torre</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Perrone</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Luoni</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Suardi</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Braf alterations are associated with complex mutational profiles in malignant melanoma</article-title>
<source/>Oncogene
          <year>2004</year>
<volume>23</volume>
<fpage>5968</fpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1207780</pub-id>
<pub-id pub-id-type="pmid">15195137</pub-id>
</element-citation>
</ref>
<ref id="B62-ijms-19-03929">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaufmann</surname>
<given-names>W.K.</given-names>
</name>
<name>
<surname>Nevis</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Helms-Deaton</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cordeiro-Stone</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>D.T.</given-names>
</name>
</person-group>
<article-title>Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression</article-title>
<source/>J. Investig. Dermatol.
          <year>2008</year>
<volume>128</volume>
<fpage>175</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="doi">10.1038/sj.jid.5700935</pub-id>
<pub-id pub-id-type="pmid">17597816</pub-id>
</element-citation>
</ref>
<ref id="B63-ijms-19-03929">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anchelin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alcaraz-PÃ©rez</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>MartÃ­nez</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>BernabÃ©-GarcÃ­a</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mulero</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Cayuela</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Premature aging in telomerase-deficient zebrafish</article-title>
<source/>Dis. Models Mech.
          <year>2013</year>
<volume>6</volume>
<fpage>1101</fpage>
<lpage>1112</lpage>
<pub-id pub-id-type="doi">10.1242/dmm.011635</pub-id>
</element-citation>
</ref>
<ref id="B64-ijms-19-03929">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robert</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Karaszewska</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Schachter</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rutkowski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mackiewicz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stroiakovski</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lichinitser</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dummer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Grange</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mortier</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Improved overall survival in melanoma with combined dabrafenib and trametinib</article-title>
<source/>N. Engl. J. Med.
          <year>2015</year>
<volume>372</volume>
<fpage>30</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1412690</pub-id>
<pub-id pub-id-type="pmid">25399551</pub-id>
</element-citation>
</ref>
<ref id="B65-ijms-19-03929">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barut</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Zon</surname>
<given-names>L.I.</given-names>
</name>
</person-group>
<article-title>Realizing the potential of zebrafish as a model for human disease</article-title>
<source/>Physiol. Genom.
          <year>2000</year>
<volume>2</volume>
<fpage>49</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1152/physiolgenomics.2000.2.2.49</pub-id>
<pub-id pub-id-type="pmid">11015581</pub-id>
</element-citation>
</ref>
<ref id="B66-ijms-19-03929">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lieschke</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Currie</surname>
<given-names>P.D.</given-names>
</name>
</person-group>
<article-title>Animal models of human disease: Zebrafish swim into view</article-title>
<source/>Nat. Rev. Genet.
          <year>2007</year>
<volume>8</volume>
<fpage>353</fpage>
<pub-id pub-id-type="doi">10.1038/nrg2091</pub-id>
<pub-id pub-id-type="pmid">17440532</pub-id>
</element-citation>
</ref>
<ref id="B67-ijms-19-03929">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ceol</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Houvras</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jane-Valbuena</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bilodeau</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Orlando</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Battisti</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Fritsch</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Hollmann</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>FerrÃ©</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>The histone methyltransferase setdb1 is recurrently amplified in melanoma and accelerates its onset</article-title>
<source/>Nature
          <year>2011</year>
<volume>471</volume>
<fpage>513</fpage>
<lpage>517</lpage>
<pub-id pub-id-type="doi">10.1038/nature09806</pub-id>
<pub-id pub-id-type="pmid">21430779</pub-id>
</element-citation>
</ref>
<ref id="B68-ijms-19-03929">
<label>68.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Houvras</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ceol</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jane-Valbuena</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ferre</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Burke</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bourque</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Uong</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Garraway</surname>
<given-names>L.</given-names>
</name>
</person-group>
<source/>Abstract# 2078: A Novel Screening Approach in Zebrafish Identifies Setdb1, a Histone Methyltransferase, as an Oncogene in Human Melanoma
          <publisher-name>AACR</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>2009</year>
</element-citation>
</ref>
<ref id="B69-ijms-19-03929">
<label>69.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Casa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bourque</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zack</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Houvras</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<source/>Genetic and Epigenetic Analysis of Tumors in a Zebrafish Model of Melanoma
          <publisher-name>AACR</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>2012</year>
</element-citation>
</ref>
<ref id="B70-ijms-19-03929">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gabellini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>GÃ³mez-Abenza</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>IbÃ¡Ã±ez-Molero</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tupone</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>PÃ©rez-Oliva</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Del Bufalo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mulero</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Interleukin 8 mediates bcl-xl-induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model</article-title>
<source/>Int. J. Cancer
          <year>2018</year>
<volume>142</volume>
<fpage>584</fpage>
<lpage>596</lpage>
<pub-id pub-id-type="doi">10.1002/ijc.31075</pub-id>
<pub-id pub-id-type="pmid">28949016</pub-id>
</element-citation>
</ref>
<ref id="B71-ijms-19-03929">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McNeill</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Paulsen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bonde</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Burnight</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>M.-Y.</given-names>
</name>
<name>
<surname>Cornell</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Cell death of melanophores in zebrafish trpm7 mutant embryos depends on melanin synthesis</article-title>
<source/>J. Investig. Dermatol.
          <year>2007</year>
<volume>127</volume>
<fpage>2020</fpage>
<lpage>2030</lpage>
<pub-id pub-id-type="doi">10.1038/sj.jid.5700710</pub-id>
<pub-id pub-id-type="pmid">17290233</pub-id>
</element-citation>
</ref>
<ref id="B72-ijms-19-03929">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasegawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maruyama</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takenaka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Furukawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Saga</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>A medaka model of cancer allowing direct observation of transplanted tumor cells in vivo at a cellular-level resolution</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2009</year>
<volume>106</volume>
<fpage>13832</fpage>
<lpage>13837</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0903999106</pub-id>
<pub-id pub-id-type="pmid">19666513</pub-id>
</element-citation>
</ref>
<ref id="B73-ijms-19-03929">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rawls</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Zebrafish kit mutation reveals primary and secondary regulation of melanocyte development during fin stripe regeneration</article-title>
<source/>Development
          <year>2000</year>
<volume>127</volume>
<fpage>3715</fpage>
<lpage>3724</lpage>
<pub-id pub-id-type="pmid">10934016</pub-id>
</element-citation>
</ref>
<ref id="B74-ijms-19-03929">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarasamma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Varikkodan</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>S.-T.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.-C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.-P.</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>C.-D.</given-names>
</name>
</person-group>
<article-title>Zebrafish: A premier vertebrate model for biomedical research in indian scenario</article-title>
<source/>Zebrafish
          <year>2017</year>
<volume>14</volume>
<fpage>589</fpage>
<lpage>605</lpage>
<pub-id pub-id-type="doi">10.1089/zeb.2017.1447</pub-id>
<pub-id pub-id-type="pmid">29023224</pub-id>
</element-citation>
</ref>
<ref id="B75-ijms-19-03929">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ju</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Spitsbergen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Eden</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.J.M.C.</given-names>
</name>
</person-group>
<article-title>Co-activation of hedgehog and akt pathways promote tumorigenesis in zebrafish</article-title>
<source/>Mol. Cancer
          <year>2009</year>
<volume>8</volume>
<fpage>40</fpage>
<pub-id pub-id-type="doi">10.1186/1476-4598-8-40</pub-id>
<pub-id pub-id-type="pmid">19555497</pub-id>
</element-citation>
</ref>
<ref id="B76-ijms-19-03929">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The genetics of a viviparous top-minnow platypoecilus; the inheritance of two kinds of melanophores</article-title>
<source/>Genetics
          <year>1927</year>
<volume>12</volume>
<fpage>253</fpage>
<pub-id pub-id-type="pmid">17246524</pub-id>
</element-citation>
</ref>
<ref id="B77-ijms-19-03929">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>HSussler</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Uber melanombildung bei bastarden von xiphophorus helleri und platypoecilus maculatus var</article-title>
<source/>Rubra. KIm. Wochschr
          <year>1928</year>
<volume>7</volume>
<fpage>1561</fpage>
<lpage>1562</lpage>
<pub-id pub-id-type="doi">10.1007/BF01748470</pub-id>
</element-citation>
</ref>
<ref id="B78-ijms-19-03929">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kosswig</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>ber bastarde der teleostier platypoecilus und xiphophorus</article-title>
<source/>Mol. Gen. Genet. MGG
          <year>1927</year>
<volume>44</volume>
<fpage>253</fpage>
<pub-id pub-id-type="doi">10.1007/BF01740990</pub-id>
</element-citation>
</ref>
<ref id="B79-ijms-19-03929">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The melanoma cell as an incompletely differentiated pigment cell</article-title>
<source/>Pigm. Cell Biol.
          <year>1959</year>
<fpage>215</fpage>
<lpage>240</lpage>
</element-citation>
</ref>
<ref id="B80-ijms-19-03929">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vielkind</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>Genetic control of cell differentiation in platyfish-swordtail melanomas</article-title>
<source/>J. Exp.Zool. Part A
          <year>1976</year>
<volume>196</volume>
<fpage>197</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1002/jez.1401960207</pub-id>
<pub-id pub-id-type="pmid">818338</pub-id>
</element-citation>
</ref>
<ref id="B81-ijms-19-03929">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Bowser</surname>
<given-names>P.R.</given-names>
</name>
</person-group>
<article-title>Selection for a dominant oncogene and large male size as a risk factor for melanoma in the xiphophorus animal model</article-title>
<source/>Mol. Ecol.
          <year>2010</year>
<volume>19</volume>
<fpage>3114</fpage>
<lpage>3123</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-294X.2010.04738.x</pub-id>
<pub-id pub-id-type="pmid">20618898</pub-id>
</element-citation>
</ref>
<ref id="B82-ijms-19-03929">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Catchen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Amores</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Braasch</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Chalopin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Volff</surname>
<given-names>J.-N.</given-names>
</name>
<name>
<surname>Lesch</surname>
<given-names>K.-P.</given-names>
</name>
</person-group>
<article-title>The genome of the platyfish, xiphophorus maculatus, provides insights into evolutionary adaptation and several complex traits</article-title>
<source/>Nat. Genet.
          <year>2013</year>
<volume>45</volume>
<fpage>567</fpage>
<lpage>572</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2604</pub-id>
<pub-id pub-id-type="pmid">23542700</pub-id>
</element-citation>
</ref>
<ref id="B83-ijms-19-03929">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wakamatsu</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Establishment of a cell line from the platyfish-swordtail hybrid melanoma</article-title>
<source/>Cancer Res.
          <year>1981</year>
<volume>41</volume>
<fpage>679</fpage>
<lpage>680</lpage>
<pub-id pub-id-type="pmid">6778612</pub-id>
</element-citation>
</ref>
<ref id="B84-ijms-19-03929">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sobel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Marquet</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kallman</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Corley</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Melanomas in platy/swordtail hybrids</article-title>
<source/>Pathol. Fish.
          <year>1975</year>
<fpage>945</fpage>
<lpage>981</lpage>
</element-citation>
</ref>
<ref id="B85-ijms-19-03929">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riehl</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kollinger</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Comparative studies on the ultrastructure of malignant melanoma in fish and human by freeze-etching and transmission electron microscopy</article-title>
<source/>J. Cancer Res. Clin. Oncol.
          <year>1984</year>
<volume>107</volume>
<fpage>21</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1007/BF00395486</pub-id>
<pub-id pub-id-type="pmid">6699072</pub-id>
</element-citation>
</ref>
<ref id="B86-ijms-19-03929">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gimenez-Conti</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Woodhead</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Harshbarger</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Kazianis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Setlow</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Nairn</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>R.B.</given-names>
</name>
</person-group>
<article-title>A proposed classification scheme for xiphophorus melanomas based on histopathologic analyses</article-title>
<source/>Mar. Biotechnol.
          <year>2001</year>
<volume>3</volume>
<fpage>S100</fpage>
<lpage>S106</lpage>
<pub-id pub-id-type="pmid">14961305</pub-id>
</element-citation>
</ref>
<ref id="B87-ijms-19-03929">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wakamatsu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Oikawa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Obika</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hirobe</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ozato</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Fish hereditary melanoma cell lines of different degrees of cell differentiation</article-title>
<source/>Dev. Growth Differ.
          <year>1984</year>
<volume>26</volume>
<fpage>503</fpage>
<lpage>513</lpage>
<pub-id pub-id-type="doi">10.1111/j.1440-169X.1984.00503.x</pub-id>
</element-citation>
</ref>
<ref id="B88-ijms-19-03929">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meierjohann</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Oxidative stress in melanocyte senescence and melanoma transformation</article-title>
<source/>Eur. J. Cell Biol.
          <year>2014</year>
<volume>93</volume>
<fpage>36</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejcb.2013.11.005</pub-id>
<pub-id pub-id-type="pmid">24342719</pub-id>
</element-citation>
</ref>
<ref id="B89-ijms-19-03929">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wood</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Berwick</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Setlow</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Timmins</surname>
<given-names>G.S.</given-names>
</name>
</person-group>
<article-title>Uv causation of melanoma in xiphophorus is dominated by melanin photosensitized oxidant production</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2006</year>
<volume>103</volume>
<fpage>4111</fpage>
<lpage>4115</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0511248103</pub-id>
<pub-id pub-id-type="pmid">16537493</pub-id>
</element-citation>
</ref>
<ref id="B90-ijms-19-03929">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchell</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Paniker</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Trono</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nairn</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>The etiology of sunlight-induced melanoma in xiphophorus hybrid fish</article-title>
<source/>Mol. Carcinog.
          <year>2007</year>
<volume>46</volume>
<fpage>679</fpage>
<lpage>684</lpage>
<pub-id pub-id-type="doi">10.1002/mc.20341</pub-id>
<pub-id pub-id-type="pmid">17477377</pub-id>
</element-citation>
</ref>
<ref id="B91-ijms-19-03929">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishikawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sakakibara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kurumado</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shimada</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Morphologic and microspectrophotometric studies on spontaneous melanomas in xiphophorus helleri</article-title>
<source/>J. Natl. Cancer Inst.
          <year>1975</year>
<volume>54</volume>
<fpage>1373</fpage>
<lpage>1378</lpage>
<pub-id pub-id-type="doi">10.1093/jnci/54.6.1373</pub-id>
<pub-id pub-id-type="pmid">1133850</pub-id>
</element-citation>
</ref>
<ref id="B92-ijms-19-03929">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Setlow</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Woodhead</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Grist</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Animal model for ultraviolet radiation-induced melanoma: Platyfish-swordtail hybrid</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1989</year>
<volume>86</volume>
<fpage>8922</fpage>
<lpage>8926</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.86.22.8922</pub-id>
<pub-id pub-id-type="pmid">2813430</pub-id>
</element-citation>
</ref>
<ref id="B93-ijms-19-03929">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahuja</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schwab</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Anders</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Lactate dehydrogenase isozymes in xiphophorin fish melanoma conditioned by the locussd</article-title>
<source/>Cell. Mol. Life Sci.
          <year>1975</year>
<volume>31</volume>
<fpage>296</fpage>
<lpage>298</lpage>
<pub-id pub-id-type="doi">10.1007/BF01922546</pub-id>
</element-citation>
</ref>
<ref id="B94-ijms-19-03929">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meierjohann</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>From mendelian to molecular genetics: The xiphophorus melanoma model</article-title>
<source/>Trends Genet.
          <year>2006</year>
<volume>22</volume>
<fpage>654</fpage>
<lpage>661</lpage>
<pub-id pub-id-type="doi">10.1016/j.tig.2006.09.013</pub-id>
<pub-id pub-id-type="pmid">17034900</pub-id>
</element-citation>
</ref>
<ref id="B95-ijms-19-03929">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adam</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Maueler</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Transcriptional activation of the melanoma inducing xmrk oncogene in xiphophorus</article-title>
<source/>Oncogene
          <year>1991</year>
<volume>6</volume>
<fpage>73</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="pmid">1846957</pub-id>
</element-citation>
</ref>
<ref id="B96-ijms-19-03929">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kazianis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gutbrod</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nairn</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>McEntire</surname>
<given-names>B.B.</given-names>
</name>
<name>
<surname>Coletta</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Borowsky</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Woodhead</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Setlow</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Localization of a cdkn2 gene in linkage group v of xiphophorus fishes defines it as a candidate for the diff tumor suppressor</article-title>
<source/>Genes Chromosomes Cancer
          <year>1998</year>
<volume>22</volume>
<fpage>210</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1098-2264(199807)22:3&lt;210::AID-GCC6&gt;3.0.CO;2-Z</pub-id>
<pub-id pub-id-type="pmid">9624532</pub-id>
</element-citation>
</ref>
<ref id="B97-ijms-19-03929">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahn</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Trono</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gimenez-Conti</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Nairn</surname>
<given-names>R.S.</given-names>
</name>
</person-group>
<article-title>Etiology of mnu-induced melanomas in xiphophorus hybrids</article-title>
<source/>Comp. Biochem. Physiol. Part C
          <year>2009</year>
<volume>149</volume>
<fpage>129</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="doi">10.1016/j.cbpc.2008.07.006</pub-id>
<pub-id pub-id-type="pmid">18692156</pub-id>
</element-citation>
</ref>
<ref id="B98-ijms-19-03929">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dimitrijevic</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Winkler</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wellbrock</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Duschl</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Altschmied</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Activation of the xmrk proto-oncogene of xiphophorus by overexpression and mutational alterations</article-title>
<source/>Oncogene
          <year>1998</year>
<volume>16</volume>
<fpage>1681</fpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1201693</pub-id>
<pub-id pub-id-type="pmid">9582016</pub-id>
</element-citation>
</ref>
<ref id="B99-ijms-19-03929">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kazianis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Coletta</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Morizot</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Osterndorff</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Nairn</surname>
<given-names>R.S.</given-names>
</name>
</person-group>
<article-title>Overexpression of a fish cdkn2 gene in a hereditary melanoma model</article-title>
<source/>Carcinogenesis
          <year>2000</year>
<volume>21</volume>
<fpage>599</fpage>
<lpage>605</lpage>
<pub-id pub-id-type="doi">10.1093/carcin/21.4.599</pub-id>
<pub-id pub-id-type="pmid">10753192</pub-id>
</element-citation>
</ref>
<ref id="B100-ijms-19-03929">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Negishi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Masada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wakamatsu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ohoka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Obika</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Epinephrine-induced changes in the cyclic nucleotide content of fish melanoma cells</article-title>
<source/>Gen. Comp. Endocrinol.
          <year>1982</year>
<volume>47</volume>
<fpage>88</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1016/0016-6480(82)90088-0</pub-id>
<pub-id pub-id-type="pmid">6282682</pub-id>
</element-citation>
</ref>
<ref id="B101-ijms-19-03929">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wittbrodt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Malitschek</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Maueler</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Raulf</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Telling</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Novel putative receptor tyrosine kinase encoded by the melanoma-inducing tu locus in xiphophorus</article-title>
<source/>Nature
          <year>1989</year>
<volume>341</volume>
<fpage>415</fpage>
<lpage>421</lpage>
<pub-id pub-id-type="doi">10.1038/341415a0</pub-id>
<pub-id pub-id-type="pmid">2797166</pub-id>
</element-citation>
</ref>
<ref id="B102-ijms-19-03929">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schartl</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dimitrijevic</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Evolutionary origin and molecular biology of the melanoma-inducing oncogene of xiphophorus</article-title>
<source/>Pigm. Cell Melanoma Res.
          <year>1994</year>
<volume>7</volume>
<fpage>428</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-0749.1994.tb00072.x</pub-id>
</element-citation>
</ref>
<ref id="B103-ijms-19-03929">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Froschauer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>KÃ¶rting</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bernhardt</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Nanda</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Schmid</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Volff</surname>
<given-names>J.-N.</given-names>
</name>
</person-group>
<article-title>Genomic plasticity and melanoma formation in the fish xiphophorus</article-title>
<source/>Mar. Biotechnol.
          <year>2001</year>
<volume>3</volume>
<fpage>S72</fpage>
<lpage>S80</lpage>
<pub-id pub-id-type="doi">10.1007/s10126-001-0049-7</pub-id>
<pub-id pub-id-type="pmid">14961302</pub-id>
</element-citation>
</ref>
<ref id="B104-ijms-19-03929">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>GÃ³mez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wellbrock</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Constitutive activation and specific signaling of the xmrk receptor in xiphophorus melanoma</article-title>
<source/>Mar. Biotechnol.
          <year>2002</year>
<volume>4</volume>
<fpage>208</fpage>
<lpage>217</lpage>
</element-citation>
</ref>
<ref id="B105-ijms-19-03929">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baudler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Duschl</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Winkler</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Altschmied</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Activation of transcription of the melanoma inducing xmrk oncogene by a gc box element</article-title>
<source/>J. Biol. Chem.
          <year>1997</year>
<volume>272</volume>
<fpage>131</fpage>
<lpage>137</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.272.1.131</pub-id>
<pub-id pub-id-type="pmid">8995238</pub-id>
</element-citation>
</ref>
<ref id="B106-ijms-19-03929">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delfgaauw</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Duschl</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wellbrock</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Froschauer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Altschmied</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Mitf-m plays an essential role in transcriptional activation and signal transduction in xiphophorus melanoma</article-title>
<source/>Gene
          <year>2003</year>
<volume>320</volume>
<fpage>117</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="doi">10.1016/S0378-1119(03)00817-5</pub-id>
<pub-id pub-id-type="pmid">14597395</pub-id>
</element-citation>
</ref>
<ref id="B107-ijms-19-03929">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woolcock</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Kallman</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Vielkind</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Differences in transcription and promoters of xmrk-1 and xmrk-2 genes suggest a role for xmrk-2 in pigment pattern development in the platyfish, xiphophorus maculatus</article-title>
<source/>Cell Growth Differ.
          <year>1994</year>
<volume>5</volume>
<fpage>575</fpage>
<lpage>583</lpage>
<pub-id pub-id-type="pmid">7522032</pub-id>
</element-citation>
</ref>
<ref id="B108-ijms-19-03929">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahuja</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schwab</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Anders</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Linkage between a regulatory locus for melanoma cell differentiation and an esterase locus in xiphophorus</article-title>
<source/>J. Hered.
          <year>1980</year>
<volume>71</volume>
<fpage>403</fpage>
<lpage>407</lpage>
<pub-id pub-id-type="doi">10.1093/oxfordjournals.jhered.a109395</pub-id>
<pub-id pub-id-type="pmid">7217655</pub-id>
</element-citation>
</ref>
<ref id="B109-ijms-19-03929">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winnemoeller</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wellbrock</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Activating mutations in the extracellular domain of the melanoma inducing receptor xmrk are tumorigenic in vivo</article-title>
<source/>Int. J. Cancer
          <year>2005</year>
<volume>117</volume>
<fpage>723</fpage>
<lpage>729</lpage>
<pub-id pub-id-type="doi">10.1002/ijc.21232</pub-id>
<pub-id pub-id-type="pmid">15957173</pub-id>
</element-citation>
</ref>
<ref id="B110-ijms-19-03929">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morcinek</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Weisser</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Geissinger</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wellbrock</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Activation of stat5 triggers proliferation and contributes to anti-apoptotic signalling mediated by the oncogenic xmrk kinase</article-title>
<source/>Oncogene
          <year>2002</year>
<volume>21</volume>
<fpage>1668</fpage>
<lpage>1678</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1205148</pub-id>
<pub-id pub-id-type="pmid">11896598</pub-id>
</element-citation>
</ref>
<ref id="B111-ijms-19-03929">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baudler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Altschmied</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Specific activation of a stat family member in xiphophorus melanoma cells</article-title>
<source/>Exp. Cell Res.
          <year>1999</year>
<volume>249</volume>
<fpage>212</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1006/excr.1999.4470</pub-id>
<pub-id pub-id-type="pmid">10366420</pub-id>
</element-citation>
</ref>
<ref id="B112-ijms-19-03929">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meierjohann</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wende</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kraiss</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wellbrock</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The oncogenic epidermal growth factor receptor variant xiphophorus melanoma receptor kinase induces motility in melanocytes by modulation of focal adhesions</article-title>
<source/>Cancer Res.
          <year>2006</year>
<volume>66</volume>
<fpage>3145</fpage>
<lpage>3152</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-2667</pub-id>
<pub-id pub-id-type="pmid">16540665</pub-id>
</element-citation>
</ref>
<ref id="B113-ijms-19-03929">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wellbrock</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lammers</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ullrich</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Association between the melanoma-inducing receptor tyrosine kinase xmrk and src family tyrosine kinases in xiphophorus</article-title>
<source/>Oncogene
          <year>1995</year>
<volume>10</volume>
<fpage>2135</fpage>
<lpage>2143</lpage>
<pub-id pub-id-type="pmid">7540277</pub-id>
</element-citation>
</ref>
<ref id="B114-ijms-19-03929">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wellbrock</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Pi3-kinase is involved in mitogenic signaling by the oncogenic receptor tyrosine kinase xiphophorus melanoma receptor kinase in fish melanoma</article-title>
<source/>Exp. Cell Res.
          <year>1999</year>
<volume>251</volume>
<fpage>340</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="doi">10.1006/excr.1999.4580</pub-id>
<pub-id pub-id-type="pmid">10471319</pub-id>
</element-citation>
</ref>
<ref id="B115-ijms-19-03929">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>I.J.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Brittelli</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Neoplastic response in japanese medaka and channel catfish exposed to n-methyl-nâ-nitro-n-nitrosoguanidine</article-title>
<source/>Toxicol. Pathol.
          <year>1996</year>
<volume>24</volume>
<fpage>696</fpage>
<lpage>706</lpage>
<pub-id pub-id-type="doi">10.1177/019262339602400604</pub-id>
<pub-id pub-id-type="pmid">8994296</pub-id>
</element-citation>
</ref>
<ref id="B116-ijms-19-03929">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyodo-Taguchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Matsudaira</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Induction of transplantable melanoma by treatment with n-methyl-nâ-nitro-n-nitrosoguanidine in an inbred strain of the teleost oryzias latipes</article-title>
<source/>J. Natl. Cancer Inst.
          <year>1984</year>
<volume>73</volume>
<fpage>1219</fpage>
<lpage>1227</lpage>
<pub-id pub-id-type="pmid">6593492</pub-id>
</element-citation>
</ref>
<ref id="B117-ijms-19-03929">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyodo-taguchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Matsudaira</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Higher susceptibility to n-methyl-nâ-nitro-n-nitrosoguanidine-induced tumorigenesis in an interstrain hybrid of the fish, oryzias latipes (medaka)</article-title>
<source/>Jpn. J. Cancer Res. GANN
          <year>1987</year>
<volume>78</volume>
<fpage>487</fpage>
<lpage>493</lpage>
<pub-id pub-id-type="pmid">3112060</pub-id>
</element-citation>
</ref>
<ref id="B118-ijms-19-03929">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Lack of ultraviolet-light inducibility of the medakafish (oryzias latipes) tumor suppressor gene p53</article-title>
<source/>Gene
          <year>2001</year>
<volume>264</volume>
<fpage>197</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1016/S0378-1119(01)00340-7</pub-id>
<pub-id pub-id-type="pmid">11250074</pub-id>
</element-citation>
</ref>
<ref id="B119-ijms-19-03929">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Armstrong</surname>
<given-names>T.N.</given-names>
</name>
<name>
<surname>Reimschuessel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>B.P.</given-names>
</name>
</person-group>
<article-title>DNA damage, histologial changes and DNA repair in larval japanese medaka (oryzias latipes) exposed to ultraviolet-b radiation</article-title>
<source/>Aquat. Toxicol.
          <year>2002</year>
<volume>58</volume>
<fpage>1</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1016/S0166-445X(01)00212-0</pub-id>
<pub-id pub-id-type="pmid">12062151</pub-id>
</element-citation>
</ref>
<ref id="B120-ijms-19-03929">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kneitz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>R.R.</given-names>
</name>
<name>
<surname>Chalopin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Postlethwait</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Germ cell and tumor associated pirnas in the medaka and xiphophorus melanoma models</article-title>
<source/>BMC Genom.
          <year>2016</year>
<volume>17</volume>
<elocation-id>357</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12864-016-2697-z</pub-id>
<pub-id pub-id-type="pmid">27183847</pub-id>
</element-citation>
</ref>
<ref id="B121-ijms-19-03929">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>BÃ©jar</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Mitf expression is sufficient to direct differentiation of medaka blastula derived stem cells to melanocytes</article-title>
<source/>Development
          <year>2003</year>
<volume>130</volume>
<fpage>6545</fpage>
<lpage>6553</lpage>
<pub-id pub-id-type="doi">10.1242/dev.00872</pub-id>
<pub-id pub-id-type="pmid">14660543</pub-id>
</element-citation>
</ref>
<ref id="B122-ijms-19-03929">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wilde</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Laisney</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Taniguchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meierjohann</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>A mutated egfr is sufficient to induce malignant melanoma with genetic background-dependent histopathologies</article-title>
<source/>J. Investig. Dermatol.
          <year>2010</year>
<volume>130</volume>
<fpage>249</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="doi">10.1038/jid.2009.213</pub-id>
<pub-id pub-id-type="pmid">19609310</pub-id>
</element-citation>
</ref>
<ref id="B123-ijms-19-03929">
<label>123.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Menescal</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>In Vivo Characterization of Genetic Factors Involved in Xmrk Driven Melanoma Formation in Medaka (Oryzias Latipes): A Closer Look at Braf, Stat5 and C-myc</article-title>
<source/>Doctoral Dissertation
          <publisher-name>UniversitÃ¤t WÃ¼rzburg</publisher-name>
<publisher-loc>WÃ¼rzburg, Germany</publisher-loc>
<year>2012</year>
</element-citation>
</ref>
<ref id="B124-ijms-19-03929">
<label>124.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Matsuzaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hosokai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mizuguchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Saya</surname>
<given-names>H.</given-names>
</name>
</person-group>
<source/>Establishment of Transgenic Medaka as a Stable Tumor Model for In Vivo Screening of Anticancer Drugs
          <publisher-name>AACR</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>2013</year>
</element-citation>
</ref>
<ref id="B125-ijms-19-03929">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelsh</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Momoi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kondoh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Furutani-Seiki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ozato</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wakamatsu</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>The tomita collection of medaka pigmentation mutants as a resource for understanding neural crest cell development</article-title>
<source/>Mech. Dev.
          <year>2004</year>
<volume>121</volume>
<fpage>841</fpage>
<lpage>859</lpage>
<pub-id pub-id-type="doi">10.1016/j.mod.2004.01.004</pub-id>
<pub-id pub-id-type="pmid">15210190</pub-id>
</element-citation>
</ref>
<ref id="B126-ijms-19-03929">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname>
<given-names>R.R.</given-names>
</name>
<name>
<surname>Kneitz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schartl</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Comparative analysis of melanoma deregulated mirnas in the medaka and xiphophorus pigment cell cancer models</article-title>
<source/>Comp. Biochem. Physiol. Part C
          <year>2014</year>
<volume>163</volume>
<fpage>64</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1016/j.cbpc.2014.01.002</pub-id>
</element-citation>
</ref>
<ref id="B127-ijms-19-03929">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meller</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Meller</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Culpepper</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Podrabsky</surname>
<given-names>J.E.</given-names>
</name>
</person-group>
<article-title>Cell cycle arrest associated with anoxia-induced quiescence, anoxic preconditioning, and embryonic diapause in embryos of the annual killifish austrofundulus limnaeus</article-title>
<source/>J. Comp. Physiol. B
          <year>2012</year>
<volume>182</volume>
<fpage>909</fpage>
<lpage>920</lpage>
<pub-id pub-id-type="doi">10.1007/s00360-012-0672-9</pub-id>
<pub-id pub-id-type="pmid">22570106</pub-id>
</element-citation>
</ref>
<ref id="B128-ijms-19-03929">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matias</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The stage-dependent resistance of the chorion to external chemical damage and its relationship to embryonic diapause in the annual fish, nothobranchius guentheri</article-title>
<source/>Experientia
          <year>1984</year>
<volume>40</volume>
<fpage>753</fpage>
<lpage>754</lpage>
<pub-id pub-id-type="doi">10.1007/BF01949761</pub-id>
<pub-id pub-id-type="pmid">6745410</pub-id>
</element-citation>
</ref>
<ref id="B129-ijms-19-03929">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Podrabsky</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Carpenter</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Hand</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>Survival of water stress in annual fish embryos: Dehydration avoidance and egg envelope amyloid fibers</article-title>
<source/>Am. J. Physiol.-Regul. Integr. Comp. Physiol.
          <year>2001</year>
<volume>280</volume>
<fpage>R123</fpage>
<lpage>R131</lpage>
<pub-id pub-id-type="doi">10.1152/ajpregu.2001.280.1.R123</pub-id>
<pub-id pub-id-type="pmid">11124142</pub-id>
</element-citation>
</ref>
<ref id="B130-ijms-19-03929">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hers</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>TavarÃ©</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Akt signalling in health and disease</article-title>
<source/>Cell. Signal.
          <year>2011</year>
<volume>23</volume>
<fpage>1515</fpage>
<lpage>1527</lpage>
<pub-id pub-id-type="doi">10.1016/j.cellsig.2011.05.004</pub-id>
<pub-id pub-id-type="pmid">21620960</pub-id>
</element-citation>
</ref>
<ref id="B131-ijms-19-03929">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mangel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kindsvater</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Bonsall</surname>
<given-names>M.B.</given-names>
</name>
</person-group>
<article-title>Evolutionary analysis of life span, competition, and adaptive radiation, motivated by the pacific rockfishes (sebastes)</article-title>
<source/>Evolution
          <year>2007</year>
<volume>61</volume>
<fpage>1208</fpage>
<lpage>1224</lpage>
<pub-id pub-id-type="doi">10.1111/j.1558-5646.2007.00094.x</pub-id>
<pub-id pub-id-type="pmid">17492972</pub-id>
</element-citation>
</ref>
<ref id="B132-ijms-19-03929">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyde</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Kimbrell</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Clifford</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lynn</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Vetter</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Multiple paternity and maintenance of genetic diversity in the live-bearing rockfishes sebastes spp.</article-title>
<source/>Mar. Ecol. Prog. Ser.
          <year>2008</year>
<volume>357</volume>
<fpage>245</fpage>
<lpage>253</lpage>
<pub-id pub-id-type="doi">10.3354/meps07296</pub-id>
</element-citation>
</ref>
<ref id="B133-ijms-19-03929">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sivasundar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Palumbi</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Parallel amino acid replacements in the rhodopsins of the rockfishes (sebastes spp.) associated with shifts in habitat depth</article-title>
<source/>J. Evol. Biol.
          <year>2010</year>
<volume>23</volume>
<fpage>1159</fpage>
<lpage>1169</lpage>
<pub-id pub-id-type="doi">10.1111/j.1420-9101.2010.01977.x</pub-id>
<pub-id pub-id-type="pmid">20345807</pub-id>
</element-citation>
</ref>
<ref id="B134-ijms-19-03929">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darias</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Andree</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Boglino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>FernÃ¡ndez</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>EstÃ©vez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gisbert</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Coordinated regulation of chromatophore differentiation and melanogenesis during the ontogeny of skin pigmentation of solea senegalensis (kaup, 1858)</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e63005</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0063005</pub-id>
<pub-id pub-id-type="pmid">23671650</pub-id>
</element-citation>
</ref>
<ref id="B135-ijms-19-03929">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okihiro</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Whipple</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Groff</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Hinton</surname>
<given-names>D.E.</given-names>
</name>
</person-group>
<article-title>Chromatophoromas and chromatophore hyperplasia in pacific rockfish (sebastes spp.)</article-title>
<source/>Cancer Res.
          <year>1993</year>
<volume>53</volume>
<fpage>1761</fpage>
<lpage>1769</lpage>
<pub-id pub-id-type="pmid">8467494</pub-id>
</element-citation>
</ref>
<ref id="B136-ijms-19-03929">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tripathi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Henz</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Lindholm</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Weigel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Breden</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dreyer</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Opsin gene duplication and diversification in the guppy, a model for sexual selection</article-title>
<source/>Proc. R. Soc. London B
          <year>2007</year>
<volume>274</volume>
<fpage>33</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1098/rspb.2006.3707</pub-id>
<pub-id pub-id-type="pmid">17015333</pub-id>
</element-citation>
</ref>
<ref id="B137-ijms-19-03929">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kodric-Brown</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Female preference and sexual selection for male coloration in the guppy (poecilia reticulata)</article-title>
<source/>Behav. Ecol. Sociobiol.
          <year>1985</year>
<volume>17</volume>
<fpage>199</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="doi">10.1007/BF00300137</pub-id>
</element-citation>
</ref>
<ref id="B138-ijms-19-03929">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grether</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Hudon</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Endler</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Carotenoid scarcity, synthetic pteridine pigments and the evolution of sexual coloration in guppies (poecilia reticulata)</article-title>
<source/>Proc. R. Soc. London B
          <year>2001</year>
<volume>268</volume>
<fpage>1245</fpage>
<lpage>1253</lpage>
<pub-id pub-id-type="doi">10.1098/rspb.2001.1624</pub-id>
</element-citation>
</ref>
<ref id="B139-ijms-19-03929">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kottler</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>FlÃ¶tenmeyer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Weigel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dreyer</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Multiple pigment cell types contribute to the black, blue, and orange ornaments of male guppies (poecilia reticulata)</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e85647</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0085647</pub-id>
<pub-id pub-id-type="pmid">24465632</pub-id>
</element-citation>
</ref>
<ref id="B140-ijms-19-03929">
<label>140.</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>Walinski</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Studying Gene Function: Creating Knockout Mice</article-title>
<year>2004</year>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.scq.ubc.ca/studying-gene-function-creating-knockout-mice/">https://www.scq.ubc.ca/studying-gene-function-creating-knockout-mice/</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2018-12-06">(accessed on 6 December 2018)</date-in-citation>
</element-citation>
</ref>
<ref id="B141-ijms-19-03929">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Mangialasche</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Andreasen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Giacobini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mantua</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mecocci</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pani</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Winblad</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Clinical trials and late-stage drug development for alzheimerâs disease: An appraisal from 1984 to 2014</article-title>
<source/>J. Intern. Med.
          <year>2014</year>
<volume>275</volume>
<fpage>251</fpage>
<lpage>283</lpage>
<pub-id pub-id-type="doi">10.1111/joim.12191</pub-id>
<pub-id pub-id-type="pmid">24605808</pub-id>
</element-citation>
</ref>
<ref id="B142-ijms-19-03929">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mak</surname>
<given-names>I.W.</given-names>
</name>
<name>
<surname>Evaniew</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ghert</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Lost in translation: Animal models and clinical trials in cancer treatment</article-title>
<source/>Am. J. Transl. Res.
          <year>2014</year>
<volume>6</volume>
<fpage>114</fpage>
<pub-id pub-id-type="pmid">24489990</pub-id>
</element-citation>
</ref>
<ref id="B143-ijms-19-03929">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mestas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>C.C.</given-names>
</name>
</person-group>
<article-title>Of mice and not men: Differences between mouse and human immunology</article-title>
<source/>J. Immunol.
          <year>2004</year>
<volume>172</volume>
<fpage>2731</fpage>
<lpage>2738</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.172.5.2731</pub-id>
<pub-id pub-id-type="pmid">14978070</pub-id>
</element-citation>
</ref>
<ref id="B144-ijms-19-03929">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shay</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jojic</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Zuk</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Rothamel</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Puyraimond-Zemmour</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wakamatsu</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Benoist</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Koller</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Regev</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Conservation and divergence in the transcriptional programs of the human and mouse immune systems</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2013</year>
<volume>110</volume>
<fpage>2946</fpage>
<lpage>2951</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1222738110</pub-id>
<pub-id pub-id-type="pmid">23382184</pub-id>
</element-citation>
</ref>
<ref id="B145-ijms-19-03929">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Husain</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Pathak</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Flotte</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wick</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Role of ultraviolet radiation in the induction of melanocytic tumors in hairless mice following 7, 12-dimethylbenz (a) anthracene application and ultraviolet irradiation</article-title>
<source/>Cancer Res.
          <year>1991</year>
<volume>51</volume>
<fpage>4964</fpage>
<lpage>4970</lpage>
<pub-id pub-id-type="pmid">1909931</pub-id>
</element-citation>
</ref>
<ref id="B146-ijms-19-03929">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Clonal analyses reveal roles of organ founding stem cells, melanocyte stem cells and melanoblasts in establishment, growth and regeneration of the adult zebrafish fin</article-title>
<source/>Development
          <year>2010</year>
<volume>137</volume>
<fpage>3931</fpage>
<lpage>3939</lpage>
<pub-id pub-id-type="doi">10.1242/dev.057075</pub-id>
<pub-id pub-id-type="pmid">20980402</pub-id>
</element-citation>
</ref>
<ref id="B147-ijms-19-03929">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dee</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Nagaraju</surname>
<given-names>R.T.</given-names>
</name>
<name>
<surname>Athanasiadis</surname>
<given-names>E.I.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>del Ama</surname>
<given-names>L.F.</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Secombes</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Cvejic</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hurlstone</surname>
<given-names>A.F.</given-names>
</name>
</person-group>
<article-title>Cd4-transgenic zebrafish reveal tissue-resident th2-and regulatory t cellâlike populations and diverse mononuclear phagocytes</article-title>
<source/>J. Immunol.
          <year>2016</year>
<volume>197</volume>
<fpage>3520</fpage>
<lpage>3530</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1600959</pub-id>
<pub-id pub-id-type="pmid">27694495</pub-id>
</element-citation>
</ref>
<ref id="B148-ijms-19-03929">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cenci</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ciapponi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gatti</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The mechanism of telomere protection: A comparison between drosophila and humans</article-title>
<source/>Chromosoma
          <year>2005</year>
<volume>114</volume>
<fpage>135</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="doi">10.1007/s00412-005-0005-9</pub-id>
<pub-id pub-id-type="pmid">16012858</pub-id>
</element-citation>
</ref>
<ref id="B149-ijms-19-03929">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serrano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.-W.</given-names>
</name>
<name>
<surname>Chin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cordon-Cardo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Beach</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>DePinho</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Role of the ink4a locus in tumor suppression and cell mortality</article-title>
<source/>Cell
          <year>1996</year>
<volume>85</volume>
<fpage>27</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)81079-X</pub-id>
<pub-id pub-id-type="pmid">8620534</pub-id>
</element-citation>
</ref>
<ref id="B150-ijms-19-03929">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>VanBrocklin</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Lastwika</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Khoury</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Holmen</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Targeted delivery of nrasq61r and cre-recombinase to post-natal melanocytes induces melanoma in ink4a/arflox/lox mice</article-title>
<source/>Pigm. Cell Melanoma Res.
          <year>2010</year>
<volume>23</volume>
<fpage>531</fpage>
<lpage>541</lpage>
<pub-id pub-id-type="doi">10.1111/j.1755-148X.2010.00717.x</pub-id>
<pub-id pub-id-type="pmid">20444198</pub-id>
</element-citation>
</ref>
<ref id="B151-ijms-19-03929">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Chinnasamy</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Varmus</surname>
<given-names>H.E.</given-names>
</name>
</person-group>
<article-title>Development of an avian leukosis-sarcoma virus subgroup a pseudotyped lentiviral vector</article-title>
<source/>J. Virol.
          <year>2001</year>
<volume>75</volume>
<fpage>9339</fpage>
<lpage>9344</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.75.19.9339-9344.2001</pub-id>
<pub-id pub-id-type="pmid">11533197</pub-id>
</element-citation>
</ref>
<ref id="B152-ijms-19-03929">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamb</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shattuck-Eidens</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Eeles</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Gruis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hussey</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Miki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Weaver-Feldhaus</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Analysis of the p16 gene (cdkn2) as a candidate for the chromosome 9p melanoma susceptibility locus</article-title>
<source/>Nat. Genet.
          <year>1994</year>
<volume>8</volume>
<fpage>22</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1038/ng0994-22</pub-id>
<pub-id pub-id-type="pmid">7987388</pub-id>
</element-citation>
</ref>
<ref id="B153-ijms-19-03929">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>D.T.</given-names>
</name>
<name>
<surname>Mumm</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Cowell</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>Evaluating human cancer cell metastasis in zebrafish</article-title>
<source/>BMC Cancer
          <year>2013</year>
<volume>13</volume>
<elocation-id>453</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2407-13-453</pub-id>
<pub-id pub-id-type="pmid">24089705</pub-id>
</element-citation>
</ref>
<ref id="B154-ijms-19-03929">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albertson</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Cresko</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Detrich</surname>
<given-names>H.W.</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Postlethwait</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Evolutionary mutant models for human disease</article-title>
<source/>Trends Genet.
          <year>2009</year>
<volume>25</volume>
<fpage>74</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1016/j.tig.2008.11.006</pub-id>
<pub-id pub-id-type="pmid">19108930</pub-id>
</element-citation>
</ref>
<ref id="B155-ijms-19-03929">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribas</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Valdivieso</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Diaz</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Piferrer</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Response to âthe importance of controlling genetic variationâRemarks on âappropriate rearing density in domesticated zebrafish to avoid masculinization: Links with the stress responseââ</article-title>
<source/>J. Exp. Biol.
          <year>2017</year>
<volume>220</volume>
<fpage>4079</fpage>
<lpage>4080</lpage>
<pub-id pub-id-type="doi">10.1242/jeb.167437</pub-id>
<pub-id pub-id-type="pmid">29093193</pub-id>
</element-citation>
</ref>
<ref id="B156-ijms-19-03929">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaj</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gersbach</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Barbas III</surname>
<given-names>C.F.</given-names>
</name>
</person-group>
<article-title>Zfn, talen, and crispr/cas-based methods for genome engineering</article-title>
<source/>Trends Biotechnol.
          <year>2013</year>
<volume>31</volume>
<fpage>397</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="doi">10.1016/j.tibtech.2013.04.004</pub-id>
<pub-id pub-id-type="pmid">23664777</pub-id>
</element-citation>
</ref>
<ref id="B157-ijms-19-03929">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Oostrom</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Cowan</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Musunuru</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Enhanced efficiency of human pluripotent stem cell genome editing through replacing talens with crisprs</article-title>
<source/>Cell Stem Cell
          <year>2013</year>
<volume>12</volume>
<fpage>393</fpage>
<lpage>394</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2013.03.006</pub-id>
<pub-id pub-id-type="pmid">23561441</pub-id>
</element-citation>
</ref>
<ref id="B158-ijms-19-03929">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Talen-mediated precise genome modification by homologous recombination in zebrafish</article-title>
<source/>Nat. Methods
          <year>2013</year>
<volume>10</volume>
<fpage>329</fpage>
<pub-id pub-id-type="doi">10.1038/nmeth.2374</pub-id>
<pub-id pub-id-type="pmid">23435258</pub-id>
</element-citation>
</ref>
<ref id="B159-ijms-19-03929">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sander</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Cade</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Khayter</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Reyon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>R.T.</given-names>
</name>
<name>
<surname>Joung</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>J.-R.J.</given-names>
</name>
</person-group>
<article-title>Targeted gene disruption in somatic zebrafish cells using engineered talens</article-title>
<source/>Nat. Biotechnol.
          <year>2011</year>
<volume>29</volume>
<fpage>697</fpage>
<pub-id pub-id-type="doi">10.1038/nbt.1934</pub-id>
<pub-id pub-id-type="pmid">21822241</pub-id>
</element-citation>
</ref>
<ref id="B160-ijms-19-03929">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Heritable gene targeting in zebrafish using customized talens</article-title>
<source/>Nat. Biotechnol.
          <year>2011</year>
<volume>29</volume>
<fpage>699</fpage>
<pub-id pub-id-type="doi">10.1038/nbt.1939</pub-id>
<pub-id pub-id-type="pmid">21822242</pub-id>
</element-citation>
</ref>
<ref id="B161-ijms-19-03929">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perles</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ta-Shma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yaacov</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Francescatto</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Edvardson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rein</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Elpeleg</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Katsanis</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>A human laterality disorder caused by a homozygous deleterious mutation in mmp21</article-title>
<source/>J. Med. Genet.
          <year>2015</year>
<volume>52</volume>
<fpage>840</fpage>
<lpage>847</lpage>
<pub-id pub-id-type="doi">10.1136/jmedgenet-2015-103336</pub-id>
<pub-id pub-id-type="pmid">26429889</pub-id>
</element-citation>
</ref>
<ref id="B162-ijms-19-03929">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Genome editing for cancer therapy: Delivery of cas9 protein/sgrna plasmid via a gold nanocluster/lipid coreâshell nanocarrier</article-title>
<source/>Adv. Sci.
          <year>2017</year>
<volume>4</volume>
<fpage>1700175</fpage>
<pub-id pub-id-type="doi">10.1002/advs.201700175</pub-id>
<pub-id pub-id-type="pmid">29201613</pub-id>
</element-citation>
</ref>
<ref id="B163-ijms-19-03929">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibney</surname>
<given-names>G.T.</given-names>
</name>
<name>
<surname>Zager</surname>
<given-names>J.S.</given-names>
</name>
</person-group>
<article-title>Clinical development of dabrafenib in braf mutant melanoma and other malignancies</article-title>
<source/>Expert Opin. Drug Metab. Toxicol.
          <year>2013</year>
<volume>9</volume>
<fpage>893</fpage>
<lpage>899</lpage>
<pub-id pub-id-type="doi">10.1517/17425255.2013.794220</pub-id>
<pub-id pub-id-type="pmid">23621583</pub-id>
</element-citation>
</ref>
<ref id="B164-ijms-19-03929">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>W.Y.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Reyon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Maeder</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>S.Q.</given-names>
</name>
<name>
<surname>Sander</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>R.T.</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Joung</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>Efficient genome editing in zebrafish using a crispr-cas system</article-title>
<source/>Nat. Biotechnol.
          <year>2013</year>
<volume>31</volume>
<fpage>227</fpage>
<pub-id pub-id-type="doi">10.1038/nbt.2501</pub-id>
<pub-id pub-id-type="pmid">23360964</pub-id>
</element-citation>
</ref>
<ref id="B165-ijms-19-03929">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manguso</surname>
<given-names>R.T.</given-names>
</name>
<name>
<surname>Pope</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Zimmer</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>F.D.</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>N.B.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>LaFleur</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Juneja</surname>
<given-names>V.R.</given-names>
</name>
</person-group>
<article-title>In vivo crispr screening identifies ptpn2 as a cancer immunotherapy target</article-title>
<source/>Nature
          <year>2017</year>
<volume>547</volume>
<fpage>413</fpage>
<pub-id pub-id-type="doi">10.1038/nature23270</pub-id>
<pub-id pub-id-type="pmid">28723893</pub-id>
</element-citation>
</ref>
<ref id="B166-ijms-19-03929">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gutierrez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Groen</surname>
<given-names>R.W.</given-names>
</name>
<name>
<surname>Baleydier</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kentsis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Marineau</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Grebliunaite</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kozakewich</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pflumio</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Phenothiazines induce pp2a-mediated apoptosis in t cell acute lymphoblastic leukemia</article-title>
<source/>J. Clin. Investig.
          <year>2014</year>
<volume>124</volume>
<fpage>644</fpage>
<lpage>655</lpage>
<pub-id pub-id-type="doi">10.1172/JCI65093</pub-id>
<pub-id pub-id-type="pmid">24401270</pub-id>
</element-citation>
</ref>
<ref id="B167-ijms-19-03929">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oppedal</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Goldsmith</surname>
<given-names>M.I.</given-names>
</name>
</person-group>
<article-title>A chemical screen to identify novel inhibitors of fin regeneration in zebrafish</article-title>
<source/>Zebrafish
          <year>2010</year>
<volume>7</volume>
<fpage>53</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1089/zeb.2009.0633</pub-id>
<pub-id pub-id-type="pmid">20384483</pub-id>
</element-citation>
</ref>
<ref id="B168-ijms-19-03929">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Namdaran</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Reinhart</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Owens</surname>
<given-names>K.N.</given-names>
</name>
<name>
<surname>Raible</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Rubel</surname>
<given-names>E.W.</given-names>
</name>
</person-group>
<article-title>Identification of modulators of hair cell regeneration in the zebrafish lateral line</article-title>
<source/>J. Neurosci.
          <year>2012</year>
<volume>32</volume>
<fpage>3516</fpage>
<lpage>3528</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3905-11.2012</pub-id>
<pub-id pub-id-type="pmid">22399774</pub-id>
</element-citation>
</ref>
<ref id="B169-ijms-19-03929">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flaherty</surname>
<given-names>K.T.</given-names>
</name>
<name>
<surname>Hodi</surname>
<given-names>F.S.</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>D.E.</given-names>
</name>
</person-group>
<article-title>From genes to drugs: Targeted strategies for melanoma</article-title>
<source/>Nat. Rev. Cancer
          <year>2012</year>
<volume>12</volume>
<fpage>349</fpage>
<pub-id pub-id-type="doi">10.1038/nrc3218</pub-id>
<pub-id pub-id-type="pmid">22475929</pub-id>
</element-citation>
</ref>
<ref id="B170-ijms-19-03929">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.-W.</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>J.-F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.-W.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q.-Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Z.-X.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>S.-H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.-Y.</given-names>
</name>
</person-group>
<article-title>Identification of a small molecule that downregulates mitf expression and mediates antimelanoma activity in vitro</article-title>
<source/>Melanoma Res.
          <year>2016</year>
<volume>26</volume>
<fpage>117</fpage>
<lpage>124</lpage>
<pub-id pub-id-type="doi">10.1097/CMR.0000000000000229</pub-id>
<pub-id pub-id-type="pmid">26684062</pub-id>
</element-citation>
</ref>
<ref id="B171-ijms-19-03929">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LÃ©vesque</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Inflammation drives wound hyperpigmentation by recruiting pigment cells to sites of tissue damage</article-title>
<source/>Dis. Models Mech.
          <year>2013</year>
<volume>6</volume>
<fpage>508</fpage>
<lpage>515</lpage>
<pub-id pub-id-type="doi">10.1242/dmm.010371</pub-id>
<pub-id pub-id-type="pmid">23104990</pub-id>
</element-citation>
</ref>
<ref id="B172-ijms-19-03929">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Mercer</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Carnevalli</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Conner</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Matsutani</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Iwanami</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Aronow</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>Mtor inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma</article-title>
<source/>Sci. Transl. Med.
          <year>2012</year>
<fpage>3003923</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3003923</pub-id>
<pub-id pub-id-type="pmid">22539746</pub-id>
</element-citation>
</ref>
<ref id="B173-ijms-19-03929">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Fogley</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Flynn</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Ablain</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saint-AndrÃ©</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Z.P.</given-names>
</name>
<name>
<surname>Do</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Laga</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Fujinaga</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Stress from nucleotide depletion activates the transcriptional regulator hexim1 to suppress melanoma</article-title>
<source/>Mol. Cell
          <year>2016</year>
<volume>62</volume>
<fpage>34</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2016.03.013</pub-id>
<pub-id pub-id-type="pmid">27058786</pub-id>
</element-citation>
</ref>
<ref id="B174-ijms-19-03929">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lasithiotakis</surname>
<given-names>K.G.</given-names>
</name>
<name>
<surname>Sinnberg</surname>
<given-names>T.W.</given-names>
</name>
<name>
<surname>Schittek</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Flaherty</surname>
<given-names>K.T.</given-names>
</name>
<name>
<surname>Kulms</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Maczey</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Garbe</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Meier</surname>
<given-names>F.E.</given-names>
</name>
</person-group>
<article-title>Combined inhibition of mapk and mtor signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells</article-title>
<source/>J. Investig. Dermatol.
          <year>2008</year>
<volume>128</volume>
<fpage>2013</fpage>
<lpage>2023</lpage>
<pub-id pub-id-type="doi">10.1038/jid.2008.44</pub-id>
<pub-id pub-id-type="pmid">18323781</pub-id>
</element-citation>
</ref>
<ref id="B175-ijms-19-03929">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amaria</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>Prieto</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Tetzlaff</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Reuben</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Andrews</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Glitza</surname>
<given-names>I.C.</given-names>
</name>
<name>
<surname>Cormier</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hwu</surname>
<given-names>W.-J.</given-names>
</name>
<name>
<surname>Tawbi</surname>
<given-names>H.A.</given-names>
</name>
</person-group>
<article-title>Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: A. single-centre, open-label, randomised, phase 2 trial</article-title>
<source/>Lancet Oncol.
          <year>2018</year>
<volume>19</volume>
<fpage>181</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1016/S1470-2045(18)30015-9</pub-id>
<pub-id pub-id-type="pmid">29361468</pub-id>
</element-citation>
</ref>
<ref id="B176-ijms-19-03929">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andtbacka</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>H.L.</given-names>
</name>
<name>
<surname>Collichio</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Amatruda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Senzer</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chesney</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Delman</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Spitler</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Puzanov</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Agarwala</surname>
<given-names>S.S.</given-names>
</name>
</person-group>
<article-title>Talimogene laherparepvec improves durable response rate in patients with advanced melanoma</article-title>
<source/>J. Clin. Oncol.
          <year>2015</year>
<volume>33</volume>
<fpage>2780</fpage>
<lpage>2788</lpage>
<pub-id pub-id-type="doi">10.1200/JCO.2014.58.3377</pub-id>
<pub-id pub-id-type="pmid">26014293</pub-id>
</element-citation>
</ref>
<ref id="B177-ijms-19-03929">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Toxicity and cytopathogenic properties toward human melanoma cells of activated cancer therapeutics in zebra fish</article-title>
<source/>Integr. Cancer Ther.
          <year>2010</year>
<volume>9</volume>
<fpage>84</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1177/1534735409355171</pub-id>
<pub-id pub-id-type="pmid">20308086</pub-id>
</element-citation>
</ref>
<ref id="B178-ijms-19-03929">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benjamin</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Hynes</surname>
<given-names>R.O.</given-names>
</name>
</person-group>
<article-title>Intravital imaging of metastasis in adult zebrafish</article-title>
<source/>BMC Cancer
          <year>2017</year>
<volume>17</volume>
<elocation-id>660</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12885-017-3647-0</pub-id>
<pub-id pub-id-type="pmid">28946867</pub-id>
</element-citation>
</ref>
<ref id="B179-ijms-19-03929">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stewart</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Poudel</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Kalueff</surname>
<given-names>A.V.</given-names>
</name>
</person-group>
<article-title>Developing zebrafish models of autism spectrum disorder (asd)</article-title>
<source/>Prog. Neuro-Psychopharmacol. Biol. Psychiatry
          <year>2014</year>
<volume>50</volume>
<fpage>27</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2013.11.014</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="ijms-19-03929-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Overview of oncogenic pathways in melanoma and possibilities for targeted inhibition, relevant for the fish models described in this review. The signaling molecule binds to the receptor resulting in phosphorylation and RAS/BRAF and Mitogen-activated protein kinase (MEK) signaling to ERK, thus driving cell growth and survival. Some drugs/inhibitors can be used to block this signaling cascade and to inhibit cancer cell proliferation and survival.</p>
</caption>
<graphic xlink:href="ijms-19-03929-g001"></graphic>
</fig>
<table-wrap id="ijms-19-03929-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">ijms-19-03929-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Development and applications of melanoma skin cancer models in zebrafish using transgenic tools.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Transgene</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Key Features</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle"><italic>mitfa</italic> : <italic>BRAF</italic> (<italic>V600E</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="middle"><italic>BRAF</italic> (<italic>V600E</italic>) expression leads to melanoma on a <italic>tp53</italic> mutant background</td>
<td align="left" colspan="1" rowspan="1" valign="middle">[<xref ref-type="bibr" rid="B21-ijms-19-03929">21</xref>,<xref ref-type="bibr" rid="B22-ijms-19-03929">22</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle"><italic>mitfa</italic> : <italic>BRAF</italic> (<italic>V600E</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Zebrafish melanoma model used for functional genetic screens to identify new oncogenes</td>
<td align="left" colspan="1" rowspan="1" valign="middle">[<xref ref-type="bibr" rid="B23-ijms-19-03929">23</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle"><italic>mitfa</italic> : <italic>BRAF</italic> (<italic>V600E</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Genetic modulation of <italic>mitf</italic> leads to melanoma regression</td>
<td align="left" colspan="1" rowspan="1" valign="middle">[<xref ref-type="bibr" rid="B24-ijms-19-03929">24</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle"><italic>mitfa</italic> : <italic>BRAF</italic> (<italic>V600E</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Zebrafish melanoma model used to screen for novel anti-melanoma drugs</td>
<td align="left" colspan="1" rowspan="1" valign="middle">[<xref ref-type="bibr" rid="B25-ijms-19-03929">25</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle"><italic>mitfa</italic> : <italic>NRAS</italic> (<italic>Q61K</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Transgenic expression of <italic>NRAS</italic> (<italic>Q61K</italic>) leads to melanomas</td>
<td align="left" colspan="1" rowspan="1" valign="middle">[<xref ref-type="bibr" rid="B26-ijms-19-03929">26</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle"><italic>mitfa</italic> : <italic>HRAS</italic> (<italic>G12V</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="middle"><italic>HRAS</italic> acts through PI3K signaling to induce melanoma</td>
<td align="left" colspan="1" rowspan="1" valign="middle">[<xref ref-type="bibr" rid="B27-ijms-19-03929">27</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle"><italic>kita</italic> : <italic>Gal4 x UAS</italic> : <italic>HRAS</italic> (<italic>G12V</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="middle"><italic>HRAS</italic> expression in <italic>kit</italic>-expressing cells lead to highly penetrant and invasive phenotypes</td>
<td align="left" colspan="1" rowspan="1" valign="middle">[<xref ref-type="bibr" rid="B28-ijms-19-03929">28</xref>,<xref ref-type="bibr" rid="B29-ijms-19-03929">29</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>krt4: cmyc x krt4:cdc6</italic>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Co-activation of c-myc and cdc6 in zebrafish skin to induce skin cancer formation</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B30-ijms-19-03929">30</xref>]</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>UAS: Upstream Activation Sequence; PI3K: Phosphoinositide 3 kinase; c-myc: cancer-myelocytomatosis.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="ijms-19-03929-t002" orientation="portrait" position="float">
<object-id pub-id-type="pii">ijms-19-03929-t002_Table 2</object-id>
<label>Table 2</label>
<caption>
<p>The present fish as a model completed genome sequence (the model fish genome is currently being fully sequenced).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Model Organism</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Disease Model</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Possibility to Maintain in Lab</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Genomic Resource</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Transgenic Methods</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">References</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Zebrafish<break></break>(<italic>Danio rerio</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Many different types of cancer</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Yes</td>
<td align="left" colspan="1" rowspan="1" valign="middle">
<italic>Danio rerio (Tuebingen)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="middle">No</td>
<td align="left" colspan="1" rowspan="1" valign="middle">[<xref ref-type="bibr" rid="B11-ijms-19-03929">11</xref>,<xref ref-type="bibr" rid="B31-ijms-19-03929">31</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Platy fish <break></break>(<italic>Xiphophorus maculatus</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Cancer, specifically melanoma</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Yes</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Three species completed</td>
<td align="left" colspan="1" rowspan="1" valign="middle">No</td>
<td align="left" colspan="1" rowspan="1" valign="middle">[<xref ref-type="bibr" rid="B32-ijms-19-03929">32</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Annual fish <break></break>(<italic>Cynolebias nigripinnis Nothobranchius rachovii</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Used as a model for aging</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Yes</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Two species completed</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Yes</td>
<td align="left" colspan="1" rowspan="1" valign="middle">[<xref ref-type="bibr" rid="B33-ijms-19-03929">33</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Medaka fish <break></break>(<italic>Oryzias latipes)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="middle">Used as a model most notably in toxicology</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Yes, short life span and is easy to breed</td>
<td align="left" colspan="1" rowspan="1" valign="middle">One species </td>
<td align="left" colspan="1" rowspan="1" valign="middle">Yes </td>
<td align="left" colspan="1" rowspan="1" valign="middle">[<xref ref-type="bibr" rid="B34-ijms-19-03929">34</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">Rockfish (<italic>Sebastes</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Complete mitochondrial genome sequences </td>
<td align="left" colspan="1" rowspan="1" valign="middle">Yes, easy to rear in the laboratory</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Five species</td>
<td align="left" colspan="1" rowspan="1" valign="middle">No</td>
<td align="left" colspan="1" rowspan="1" valign="middle">[<xref ref-type="bibr" rid="B35-ijms-19-03929">35</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Guppy <break></break>(<italic>Poecilia reticulate</italic>)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Model systems for the study of evolution, ecology, behavior, tumor genetics and genomics</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Yes</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">One species</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B36-ijms-19-03929">36</xref>]</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>